| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.42e-09 | 37 | 228 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.30e-09 | 38 | 228 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | actin binding | GIPC1 MYLK MAP2 CD2AP LRRK2 TMOD2 CLASP2 SYNE2 MICAL3 DMD UTRN SYNE1 RDX SYNE3 CTNNA3 SNTG2 DIXDC1 SSH2 MYBPC2 | 2.76e-06 | 479 | 228 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 1.44e-05 | 5 | 228 | 3 | GO:0004749 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.44e-05 | 5 | 228 | 3 | GO:0140444 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 2.86e-05 | 6 | 228 | 3 | GO:0016778 | |
| GeneOntologyMolecularFunction | cadherin binding | GIPC1 SEPTIN9 CD2AP CKAP5 CDH20 AHNAK GCN1 DOCK9 RDX CTNNA3 TXNDC9 CDH6 CDH12 HDLBP | 3.78e-05 | 339 | 228 | 14 | GO:0045296 |
| GeneOntologyMolecularFunction | ADP binding | 2.13e-04 | 48 | 228 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.27e-04 | 11 | 228 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | zinc ion binding | CYLD ERVK-6 ATP7B ERVK-21 ERVK-9 ERVK-10 ZNF638 ERVK-19 HERC2 DMD ERVK-24 MMP16 UTRN NPEPPS POLE UBR4 BAZ1B MORC2 THAP11 ZFHX4 ERVK-8 TRIM13 ZMYM5 | 2.34e-04 | 891 | 228 | 23 | GO:0008270 |
| GeneOntologyMolecularFunction | dystroglycan binding | 3.00e-04 | 12 | 228 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.26e-04 | 230 | 228 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GIPC1 MYLK MAP2 CD2AP KIF1B LRRK2 CKAP5 TMOD2 CLASP2 NUF2 SYNE2 MICAL3 DMD UTRN DIP2B SYNE1 RDX GRIA1 SMTNL1 SYNE3 TTLL11 CTNNA3 SNTG2 DIXDC1 SSH2 MYBPC2 | 3.55e-04 | 1099 | 228 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | succinate-CoA ligase (ADP-forming) activity | 3.86e-04 | 3 | 228 | 2 | GO:0004775 | |
| GeneOntologyMolecularFunction | succinate-CoA ligase activity | 3.86e-04 | 3 | 228 | 2 | GO:0004774 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 PRPS2 ERVK-6 MYLK RPS6KA5 LRRK2 DGKH ERVK-10 PGK1 PRPS1L1 STK3 PHKA1 NMRK1 AK4 WNK2 POLE POLRMT BAZ1B DGKD RET CCNE1 ERVK-8 PRPS1 | 4.82e-04 | 938 | 228 | 23 | GO:0016772 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.87e-04 | 14 | 228 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.01e-04 | 38 | 228 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.45e-03 | 20 | 228 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | GIPC1 SEPTIN9 CD2AP CKAP5 CDH20 AHNAK DMD GCN1 UTRN DOCK9 RDX CTNNA3 TXNDC9 CDH6 CDH12 HDLBP | 1.49e-03 | 599 | 228 | 16 | GO:0050839 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDH20 PCDH15 PCDHGA11 PCDH11Y RET PCDHB18P CELSR3 CDH6 PCDH9 CDH12 | 7.82e-06 | 187 | 228 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 2.60e-05 | 6 | 228 | 3 | GO:0046391 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 2.60e-05 | 6 | 228 | 3 | GO:0006015 | |
| GeneOntologyBiologicalProcess | localization of cell | 4.52e-05 | 7 | 228 | 3 | GO:0051674 | |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 1.28e-05 | 5 | 229 | 3 | GO:0002189 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.98e-05 | 8 | 229 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.47e-04 | 10 | 229 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | proteasome accessory complex | 1.48e-04 | 25 | 229 | 4 | GO:0022624 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 2.01e-04 | 11 | 229 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 2.01e-04 | 11 | 229 | 3 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 2.01e-04 | 11 | 229 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 2.01e-04 | 11 | 229 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | succinate-CoA ligase complex | 3.56e-04 | 3 | 229 | 2 | GO:0042709 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.32e-04 | 14 | 229 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | azurophil granule lumen | 4.97e-04 | 91 | 229 | 6 | GO:0035578 | |
| GeneOntologyCellularComponent | syntrophin complex | 7.07e-04 | 4 | 229 | 2 | GO:0016013 | |
| GeneOntologyCellularComponent | midbody | 7.93e-04 | 222 | 229 | 9 | GO:0030496 | |
| GeneOntologyCellularComponent | vacuolar lumen | 7.95e-04 | 178 | 229 | 8 | GO:0005775 | |
| GeneOntologyCellularComponent | proteasome complex | 8.40e-04 | 67 | 229 | 5 | GO:0000502 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 9.38e-04 | 18 | 229 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | AP-4 adaptor complex | 1.17e-03 | 5 | 229 | 2 | GO:0030124 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 1.29e-03 | 20 | 229 | 3 | GO:0016010 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.29e-03 | 20 | 229 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.34e-03 | 110 | 229 | 6 | GO:0120111 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.49e-03 | 21 | 229 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | filopodium membrane | 1.49e-03 | 21 | 229 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | proteasome regulatory particle | 1.71e-03 | 22 | 229 | 3 | GO:0005838 | |
| Domain | ARM-type_fold | GPRASP1 LRRK2 CKAP5 PSMD1 CLASP2 RYR3 NBEAL2 ASPM GCN1 AP3D1 ARMC6 DOCK9 UBR4 VIRMA AP4E1 UNC45B ELMO2 IPO13 AP4B1 EIF4G3 | 4.13e-09 | 339 | 221 | 20 | IPR016024 |
| Domain | ARM-like | GPRASP1 LRRK2 CKAP5 PSMD1 CLASP2 NBEAL2 ASPM GCN1 AP3D1 ARMC6 THAP11 AP4E1 UNC45B ELMO2 IPO13 AP4B1 | 1.47e-07 | 270 | 221 | 16 | IPR011989 |
| Domain | Cadherin | DCHS2 FREM1 CDH20 PCDH15 PCDHGA11 PCDH11Y RET CELSR3 CDH6 PCDH9 CDH12 | 1.57e-07 | 118 | 221 | 11 | IPR002126 |
| Domain | - | GPRASP1 LRRK2 CKAP5 PSMD1 CLASP2 ASPM GCN1 AP3D1 ARMC6 AP4E1 UNC45B ELMO2 IPO13 AP4B1 | 4.26e-07 | 222 | 221 | 14 | 1.25.10.10 |
| Domain | Cadherin | DCHS2 CDH20 PCDH15 PCDHGA11 PCDH11Y RET CELSR3 CDH6 PCDH9 CDH12 | 9.42e-07 | 113 | 221 | 10 | PF00028 |
| Domain | - | DCHS2 CDH20 PCDH15 PCDHGA11 PCDH11Y RET CELSR3 CDH6 PCDH9 CDH12 | 1.02e-06 | 114 | 221 | 10 | 2.60.40.60 |
| Domain | CADHERIN_2 | DCHS2 CDH20 PCDH15 PCDHGA11 PCDH11Y RET CELSR3 CDH6 PCDH9 CDH12 | 1.02e-06 | 114 | 221 | 10 | PS50268 |
| Domain | CA | DCHS2 CDH20 PCDH15 PCDHGA11 PCDH11Y RET CELSR3 CDH6 PCDH9 CDH12 | 1.11e-06 | 115 | 221 | 10 | SM00112 |
| Domain | Cadherin-like | DCHS2 CDH20 PCDH15 PCDHGA11 PCDH11Y RET CELSR3 CDH6 PCDH9 CDH12 | 1.20e-06 | 116 | 221 | 10 | IPR015919 |
| Domain | PRib_PP_synth_CS | 1.63e-06 | 3 | 221 | 3 | IPR000842 | |
| Domain | PRPP_SYNTHASE | 1.63e-06 | 3 | 221 | 3 | PS00114 | |
| Domain | Cadherin_CS | 5.91e-06 | 109 | 221 | 9 | IPR020894 | |
| Domain | Spectrin | 6.27e-06 | 23 | 221 | 5 | PF00435 | |
| Domain | KASH | 6.48e-06 | 4 | 221 | 3 | PS51049 | |
| Domain | KASH | 6.48e-06 | 4 | 221 | 3 | PF10541 | |
| Domain | KASH | 6.48e-06 | 4 | 221 | 3 | IPR012315 | |
| Domain | KASH | 6.48e-06 | 4 | 221 | 3 | SM01249 | |
| Domain | CADHERIN_1 | 7.95e-06 | 113 | 221 | 9 | PS00232 | |
| Domain | CH | 1.15e-05 | 65 | 221 | 7 | SM00033 | |
| Domain | Pribosyltran_N | 1.61e-05 | 5 | 221 | 3 | PF13793 | |
| Domain | Pribosyl_synth | 1.61e-05 | 5 | 221 | 3 | PF14572 | |
| Domain | Rib-P_diPkinase | 1.61e-05 | 5 | 221 | 3 | IPR005946 | |
| Domain | Pribosyltran_N | 1.61e-05 | 5 | 221 | 3 | IPR029099 | |
| Domain | CH | 1.88e-05 | 70 | 221 | 7 | PF00307 | |
| Domain | - | 2.07e-05 | 71 | 221 | 7 | 1.10.418.10 | |
| Domain | Spectrin_repeat | 2.09e-05 | 29 | 221 | 5 | IPR002017 | |
| Domain | CH | 2.48e-05 | 73 | 221 | 7 | PS50021 | |
| Domain | CH-domain | 2.96e-05 | 75 | 221 | 7 | IPR001715 | |
| Domain | SPEC | 3.44e-05 | 32 | 221 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.44e-05 | 32 | 221 | 5 | IPR018159 | |
| Domain | Succ_CoA_synthase_bsu | 1.39e-04 | 2 | 221 | 2 | IPR005809 | |
| Domain | Dystrophin | 1.39e-04 | 2 | 221 | 2 | IPR016344 | |
| Domain | ACTININ_2 | 1.42e-04 | 23 | 221 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.42e-04 | 23 | 221 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.42e-04 | 23 | 221 | 4 | IPR001589 | |
| Domain | HEAT_REPEAT | 1.79e-04 | 70 | 221 | 6 | PS50077 | |
| Domain | Pribosyltran | 2.51e-04 | 11 | 221 | 3 | PF00156 | |
| Domain | Ran_BP1 | 3.32e-04 | 12 | 221 | 3 | PF00638 | |
| Domain | RANBD1 | 3.32e-04 | 12 | 221 | 3 | PS50196 | |
| Domain | PRibTrfase_dom | 3.32e-04 | 12 | 221 | 3 | IPR000836 | |
| Domain | PRTase-like | 3.32e-04 | 12 | 221 | 3 | IPR029057 | |
| Domain | - | 3.32e-04 | 12 | 221 | 3 | 3.40.50.2020 | |
| Domain | UCP038083_PDZ | 4.15e-04 | 3 | 221 | 2 | IPR017379 | |
| Domain | Succ-CoA_synthase_bsu_CS | 4.15e-04 | 3 | 221 | 2 | IPR017866 | |
| Domain | Beta-propeller_rpt_TECPR | 4.15e-04 | 3 | 221 | 2 | IPR006624 | |
| Domain | ATP-grasp_succ-CoA_synth-type | 4.15e-04 | 3 | 221 | 2 | IPR013650 | |
| Domain | TECPR | 4.15e-04 | 3 | 221 | 2 | SM00706 | |
| Domain | ATP-grasp_2 | 4.15e-04 | 3 | 221 | 2 | PF08442 | |
| Domain | CDC48_domain_2-like | 4.15e-04 | 3 | 221 | 2 | IPR029067 | |
| Domain | - | 4.15e-04 | 3 | 221 | 2 | 3.10.330.10 | |
| Domain | SUCCINYL_COA_LIG_3 | 4.15e-04 | 3 | 221 | 2 | PS01217 | |
| Domain | RanBD | 4.28e-04 | 13 | 221 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 4.28e-04 | 13 | 221 | 3 | IPR000156 | |
| Domain | ATP_GRASP | 5.40e-04 | 14 | 221 | 3 | PS50975 | |
| Domain | ATP-grasp | 5.40e-04 | 14 | 221 | 3 | IPR011761 | |
| Domain | PH_dom-like | KIF1B RGPD1 DGKH NBEAL2 RGPD2 RANBP2 DOCK9 RDX DGKD ELMO2 RALGPS1 SBF2 SNTG2 PHLPP2 | 5.77e-04 | 426 | 221 | 14 | IPR011993 |
| Domain | HEAT | 6.10e-04 | 58 | 221 | 5 | IPR000357 | |
| Domain | Adaptin_N | 6.69e-04 | 15 | 221 | 3 | PF01602 | |
| Domain | - | 6.69e-04 | 15 | 221 | 3 | 3.30.1490.20 | |
| Domain | Clathrin/coatomer_adapt-like_N | 6.69e-04 | 15 | 221 | 3 | IPR002553 | |
| Domain | CoA_ligase | 8.23e-04 | 4 | 221 | 2 | IPR005811 | |
| Domain | Succinyl-CoA_synth-like | 8.23e-04 | 4 | 221 | 2 | IPR016102 | |
| Domain | CLASP_N | 8.23e-04 | 4 | 221 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 8.23e-04 | 4 | 221 | 2 | IPR024395 | |
| Domain | Ligase_CoA | 8.23e-04 | 4 | 221 | 2 | PF00549 | |
| Domain | - | 8.23e-04 | 4 | 221 | 2 | 3.40.50.261 | |
| Domain | ATP_grasp_subdomain_1 | 1.17e-03 | 18 | 221 | 3 | IPR013815 | |
| Domain | ZF_ZZ_2 | 1.17e-03 | 18 | 221 | 3 | PS50135 | |
| Domain | - | 1.17e-03 | 18 | 221 | 3 | 3.30.470.20 | |
| Domain | ZF_ZZ_1 | 1.17e-03 | 18 | 221 | 3 | PS01357 | |
| Domain | ZZ | 1.17e-03 | 18 | 221 | 3 | PF00569 | |
| Domain | NAC | 1.36e-03 | 5 | 221 | 2 | SM01407 | |
| Domain | DEFENSIN | 1.36e-03 | 5 | 221 | 2 | PS00269 | |
| Domain | Defensin_propep | 1.36e-03 | 5 | 221 | 2 | IPR002366 | |
| Domain | Defensin_1 | 1.36e-03 | 5 | 221 | 2 | PF00323 | |
| Domain | Defensin_propep | 1.36e-03 | 5 | 221 | 2 | PF00879 | |
| Domain | Alpha-defensin | 1.36e-03 | 5 | 221 | 2 | IPR006081 | |
| Domain | Protocadherin | 1.36e-03 | 5 | 221 | 2 | PF08374 | |
| Domain | Alpha-defensin_pro | 1.36e-03 | 5 | 221 | 2 | IPR016327 | |
| Domain | Asp_de-COase-like_dom | 1.36e-03 | 5 | 221 | 2 | IPR009010 | |
| Domain | Protocadherin | 1.36e-03 | 5 | 221 | 2 | IPR013585 | |
| Domain | Znf_ZZ | 1.38e-03 | 19 | 221 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.38e-03 | 19 | 221 | 3 | SM00291 | |
| Domain | BRK | 2.03e-03 | 6 | 221 | 2 | SM00592 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 2.03e-03 | 6 | 221 | 2 | IPR002715 | |
| Domain | EF-hand_dom_typ1 | 2.03e-03 | 6 | 221 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 2.03e-03 | 6 | 221 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 2.03e-03 | 6 | 221 | 2 | PF09068 | |
| Domain | EF-hand_3 | 2.03e-03 | 6 | 221 | 2 | PF09069 | |
| Domain | BRK_domain | 2.03e-03 | 6 | 221 | 2 | IPR006576 | |
| Domain | NAC | 2.03e-03 | 6 | 221 | 2 | PF01849 | |
| Domain | NAC_AB | 2.03e-03 | 6 | 221 | 2 | PS51151 | |
| Domain | BRK | 2.03e-03 | 6 | 221 | 2 | PF07533 | |
| Domain | - | KIF1B RGPD1 DGKH RGPD2 RANBP2 DOCK9 RDX DGKD ELMO2 RALGPS1 SBF2 PHLPP2 | 2.49e-03 | 391 | 221 | 12 | 2.30.29.30 |
| Domain | GCC2_Rab_bind | 2.81e-03 | 7 | 221 | 2 | IPR032023 | |
| Domain | Rab_bind | 2.81e-03 | 7 | 221 | 2 | PF16704 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | RGPD1 CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 NUF2 PSME1 HERC2 DYNC1H1 RGPD2 RANBP2 RFC4 CCNA2 CCNE1 | 5.80e-07 | 271 | 163 | 15 | MM15388 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | RGPD1 CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 NUF2 PSME1 DYNC1H1 RGPD2 RANBP2 EHHADH | 2.46e-06 | 193 | 163 | 12 | MM14890 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | RGPD1 CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 NUF2 PSME1 DYNC1H1 RGPD2 RANBP2 EHHADH | 1.76e-05 | 234 | 163 | 12 | MM14898 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 NUF2 PSME1 HERC2 DYNC1H1 RANBP2 RFC4 CCNA2 CCNE1 | 3.36e-05 | 291 | 163 | 13 | M16647 |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 5.37e-05 | 58 | 163 | 6 | MM14715 | |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 6.51e-05 | 60 | 163 | 6 | M1081 | |
| Pathway | REACTOME_SYNTHESIS_OF_DNA | 8.00e-05 | 121 | 163 | 8 | M5224 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 9.39e-05 | 64 | 163 | 6 | MM15386 | |
| Pathway | REACTOME_DNA_REPLICATION | 1.01e-04 | 125 | 163 | 8 | MM15380 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.25e-04 | 129 | 163 | 8 | MM14894 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 1.32e-04 | 68 | 163 | 6 | M27672 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 1.55e-04 | 70 | 163 | 6 | MM15389 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.58e-04 | 100 | 163 | 7 | MM14561 | |
| Pathway | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 1.68e-04 | 71 | 163 | 6 | MM15370 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | FILIP1 MYLK RGPD1 CKAP5 CLASP2 NUF2 FAM13B SAMM50 FAM135A DYNC1H1 VCP RGPD2 RANBP2 RHOBTB3 DOCK9 CAV1 CCNE1 EHHADH ELMO2 | 1.81e-04 | 649 | 163 | 19 | MM15690 |
| Pathway | REACTOME_G1_S_TRANSITION | 2.02e-04 | 104 | 163 | 7 | MM15376 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.32e-04 | 141 | 163 | 8 | MM15266 | |
| Pathway | REACTOME_S_PHASE | 2.94e-04 | 146 | 163 | 8 | MM15378 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.80e-04 | 191 | 163 | 9 | M29614 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.15e-04 | 117 | 163 | 7 | MM15387 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 4.49e-04 | 85 | 163 | 6 | M27674 | |
| Pathway | KEGG_PURINE_METABOLISM | 5.21e-04 | 159 | 163 | 8 | M14314 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 6.09e-04 | 90 | 163 | 6 | MM15371 | |
| Pathway | REACTOME_S_PHASE | 6.14e-04 | 163 | 163 | 8 | M3158 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD1 CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 NUF2 PSME1 HERC2 DYNC1H1 RGPD2 RANBP2 POLE RFC4 CCNA2 CCNE1 EHHADH | 6.18e-04 | 603 | 163 | 17 | MM14635 |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 6.23e-04 | 15 | 163 | 3 | M27682 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 6.23e-04 | 15 | 163 | 3 | MM15404 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 6.85e-04 | 92 | 163 | 6 | M27666 | |
| Pathway | REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS | 6.86e-04 | 61 | 163 | 5 | M27563 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 7.39e-04 | 62 | 163 | 5 | MM15181 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 7.81e-04 | 130 | 163 | 7 | MM15146 | |
| Pathway | WP_PURINE_METABOLISM | 8.40e-04 | 171 | 163 | 8 | MM15909 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 9.18e-04 | 65 | 163 | 5 | M27439 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.01e-03 | 99 | 163 | 6 | MM14986 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.09e-03 | 18 | 163 | 3 | MM1549 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.14e-03 | 40 | 163 | 4 | M47748 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPS2 GIPC1 DNAJB11 MRPL12 SEPTIN9 CD2AP NACA CKAP5 NASP PSMD1 PSMD3 PSMD7 CLASP2 PSME1 PGK1 PHKA1 AHNAK USP7 MICAL3 GCN1 AP3D1 DYNC1H1 VCP STRN3 RANBP2 HYOU1 NPEPPS UBR4 RDX RFC4 ESF1 IVNS1ABP NOP58 INA PREP EIF4G3 LSM14B HDLBP PRPS1 | 4.50e-17 | 1149 | 230 | 39 | 35446349 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJB11 SEPTIN9 NACA CKAP5 PSMD1 PSMD3 PSMD7 SUCLG2 PGK1 GUF1 CDC40 SERPINB3 AHNAK ASPM USP7 PPP1R37 ZNF638 SAMM50 HERC2 GCN1 UTRN AP3D1 DYNC1H1 VCP RANBP2 NPEPPS POLE UBR4 POLRMT BAZ1B DGKD LRRC40 RFC4 ESF1 NOP58 TXNDC9 EXOC1 DHX34 HDLBP | 9.43e-15 | 1353 | 230 | 39 | 29467282 |
| Pubmed | DNAJB11 PSMD1 PSMD3 PSMD7 CLASP2 PSME1 PHKA1 PTPN9 AHNAK SYNE2 USP7 PPP1R37 ZNF638 MICAL3 UTP3 HERC2 DMD STX17 GCN1 UTRN ABCC1 RANBP2 HYOU1 POLR2D ESF1 GLMN CNNM1 KMT2D SLC4A1AP SBF2 SSH2 TRIM13 PHLPP2 HDLBP | 2.17e-14 | 1049 | 230 | 34 | 27880917 | |
| Pubmed | CKAP5 PSMD1 ME2 PGK1 AHNAK SYNE2 USP7 ZNF638 HERC2 GCN1 UTRN DYNC1H1 VCP RANBP2 HYOU1 NPEPPS POLE UBR4 POLRMT BAZ1B VIRMA ESF1 NOP58 INA PREP EIF4G3 HDLBP | 4.46e-14 | 653 | 230 | 27 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A VPS13C NACA CKAP5 NASP PSMD1 PSMD3 PSMD7 CLASP2 SUCLA2 ME2 PGK1 CDC40 SERPINB3 USP7 SAMM50 UTP3 GCN1 DYNC1H1 RANBP2 HYOU1 NPEPPS SYNE1 POLE UBR4 POLRMT BAZ1B RDX LRRC40 CPOX RFC4 ESF1 IVNS1ABP GLMN NOP58 SEC23IP HDLBP PRPS1 | 2.40e-13 | 1425 | 230 | 38 | 30948266 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPL12 VPS13C PEX1 PSMD1 PSMD7 DGKH NUF2 SUCLG2 SUCLA2 ME2 NGRN GUF1 CDC40 SYNE2 MIEF1 AK4 SAMM50 UTP3 HERC2 CARS2 VCP DIP2B STRN3 NDUFAF5 HYOU1 SYNE1 POLE UBR4 POLRMT LRRC40 CAV1 CPOX ESF1 GLMN NOP58 SEC23IP TXNDC9 TRIM13 | 1.05e-12 | 1496 | 230 | 38 | 32877691 |
| Pubmed | GIPC1 CYLD GPRASP1 PDE1B RGPD1 CKAP5 CLASP2 FYCO1 PGK1 PTPN9 SYNE2 HERC2 DYNC1H1 WNK2 DIP2B RGPD2 STRN3 RANBP2 NPEPPS SYNE1 UBR4 RDX GRIA1 VIRMA INA SEC23IP DIXDC1 SSH2 AFF4 PROX1 | 2.29e-12 | 963 | 230 | 30 | 28671696 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 DCHS2 MAP2 SEPTIN9 NASP PSMD7 CLASP2 RYR3 NBEAL2 USP7 MICAL3 UTP3 AP3D1 DPYD NPEPPS DOCK9 POLRMT CHD9 MORC2 SLC4A1AP SAP30BP ANKRD11 | 3.00e-12 | 497 | 230 | 22 | 36774506 |
| Pubmed | CYLD DNAJB11 MAP2 MRPL12 PSMD7 CLASP2 PLD3 SUCLA2 ME2 GUF1 SYNE2 ASPM AK4 SAMM50 HERC2 CARS2 FAM135A AP3D1 VCP FRAS1 HYOU1 SYNE1 POLE UBR4 POLRMT BAZ1B LRRC40 CAV1 ESF1 NOP58 SYNE3 SLC4A1AP ANKRD11 TRIM13 EIF4G3 HDLBP | 1.74e-11 | 1487 | 230 | 36 | 33957083 | |
| Pubmed | DNAJB11 NACA PSMD1 PSMD3 PSMD7 PSME1 PLD3 SUCLG2 SUCLA2 HPSE AHNAK SYNE2 USP7 MICAL3 SAMM50 STX17 GCN1 AP3D1 DYNC1H1 VCP ABCC1 RANBP2 HYOU1 NPEPPS UBR4 POLRMT RFC4 CCNA2 CCNE1 GLMN NOP58 IPO13 EXOC1 TRIM13 PRPS1 | 3.10e-11 | 1440 | 230 | 35 | 30833792 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MRPL12 SEPTIN9 NACA CKAP5 NASP PSMD7 ME2 PGK1 AHNAK USP7 ZNF638 GCN1 UTRN AP3D1 VCP STRN3 RANBP2 BTF3L4 BAZ1B RDX RFC4 ESF1 SAP30BP SEC23IP TXNDC9 EIF4G3 AFF4 HDLBP | 3.20e-11 | 934 | 230 | 28 | 33916271 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 MAP2 VPS13C SEPTIN9 CD2AP KIF1B PSMD1 DGKH CLASP2 PLD3 SUCLA2 ME2 TECPR2 ZNF638 MICAL3 CHD6 SAMM50 MMP16 STX17 UTRN WNK2 DIP2B BTF3L4 NPEPPS PCDH11Y CHD9 NXN RALGPS1 TTLL11 SBF2 ANKRD11 SNTG2 EIF4G3 AFF4 ZNF44 | 7.68e-11 | 1489 | 230 | 35 | 28611215 |
| Pubmed | GIPC1 CYLD GPRASP1 DCHS2 KIF1B CKAP5 NASP PSMD1 PSMD7 PSME1 PGK1 RYR3 GUF1 USP7 CHD6 HERC2 ZNF606 CARS2 UTRN DYNC1H1 VCP SYNE1 RHOBTB3 UBR4 RDX CHD9 CELSR3 SEC23IP EXOC1 EIF4G3 ZMYM5 AFF4 | 1.30e-10 | 1285 | 230 | 32 | 35914814 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | MRPL12 C9orf78 CD2AP NACA RGPD1 CKAP5 CLASP2 NUF2 PGK1 DEFA1 STK3 CDC40 AHNAK ASPM MICAL3 SAMM50 HERC2 GCN1 DYNC1H1 VCP RGPD2 STRN3 RANBP2 SYNE1 CPS1 NRIP3 CCNA2 THAP11 NOP58 DIXDC1 | 1.93e-10 | 1155 | 230 | 30 | 20360068 |
| Pubmed | GIPC1 DNAJB11 ATP7B CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 FYCO1 NUF2 PGK1 NBEAL2 AHNAK HERC2 GCN1 AP3D1 DYNC1H1 DIP2B ABCC1 RANBP2 HYOU1 DOCK9 UBR4 LRRC40 NOP58 SYNE3 PLXNC1 PREP EXOC1 DHX34 | 2.52e-10 | 1168 | 230 | 30 | 19946888 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CLASP2 FYCO1 NBEAL2 AHNAK USP7 C19orf44 MICAL3 HERC2 GCN1 AP3D1 DYNC1H1 WNK2 GAREM1 FRAS1 POLE DOCK9 UBR4 POLRMT POMGNT1 RGS16 THAP11 CCNE1 KMT2D SYNE3 CELSR3 RALGPS1 SBF2 ANKRD11 DHX34 | 3.14e-10 | 1105 | 230 | 29 | 35748872 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPS2 MRPL12 C9orf78 SEPTIN9 NACA CKAP5 PSMD1 PSMD3 CLASP2 PSME1 PGK1 AHNAK SYNE2 USP7 ZNF638 CARS2 GCN1 AP3D1 DYNC1H1 VCP RANBP2 BTF3L4 HYOU1 UBR4 POLR2D RDX LRRC40 CPS1 RFC4 NOP58 SLC4A1AP HDLBP PRPS1 | 3.48e-10 | 1415 | 230 | 33 | 28515276 |
| Pubmed | CD2AP RGPD1 CKAP5 PSMD1 AHNAK CHD6 GCN1 UTRN RGPD2 RANBP2 UBR4 POLRMT TXNIP KMT2D ZFHX4 SEC23IP ZMYM5 PROX1 | 4.76e-10 | 418 | 230 | 18 | 34709266 | |
| Pubmed | CYLD C9orf78 VPS13C KIF1B LRRK2 PSMD7 CLASP2 PGK1 AHNAK ZNF638 MIEF1 GCN1 FAM135A AP3D1 DYNC1H1 CAV1 ESF1 AP4E1 LRIG3 SEC23IP TXNDC9 EIF4G3 PCDH9 PRPS1 | 4.97e-10 | 777 | 230 | 24 | 35844135 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | DNAJB11 NACA CKAP5 NASP PSMD1 PSMD3 RYR3 DEFA3 USP7 GCN1 VCP NOP58 CELSR3 HDLBP | 5.48e-10 | 231 | 230 | 14 | 36597993 |
| Pubmed | PRPS2 DENND4A MYLK RGPD1 PSMD1 PSMD3 PSMD7 PGK1 PRPS1L1 EFCAB12 AHNAK SYNE2 ASPM CHD6 DMD AP3D1 RGPD2 STRN3 RANBP2 HYOU1 PCDHGA11 SYNE1 UBR4 RDX GRIA1 CPOX ESF1 INA SAP30BP SEC23IP EIF4G3 MYBPC2 PRPS1 | 5.61e-10 | 1442 | 230 | 33 | 35575683 | |
| Pubmed | CYLD GPRASP1 DNAJB11 MAP2 SEPTIN9 NACA RGPD1 CKAP5 PSMD1 PSMD3 PSMD7 SUCLA2 PGK1 USP7 GCN1 WNK2 VCP ARMC6 RGPD2 STRN3 RANBP2 BTF3L4 DOCK9 UBR4 GRIA1 INA EXOC1 EIF4G3 HDLBP | 6.29e-10 | 1139 | 230 | 29 | 36417873 | |
| Pubmed | MAP2 SEPTIN9 KIF1B CKAP5 TMOD2 PSMD3 CLASP2 PLD3 SUCLA2 PGK1 USP7 MICAL3 SAMM50 DMD UTRN AP3D1 DYNC1H1 WNK2 VCP STRN3 HYOU1 NPEPPS SYNE1 RDX GRIA1 VIRMA INA EXOC1 SSH2 EIF4G3 HDLBP PRPS1 | 1.85e-09 | 1431 | 230 | 32 | 37142655 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GIPC1 MRPL12 SEPTIN9 CD2AP KIF1B NACA CKAP5 NASP PSME1 SUCLG2 SUCLA2 ME2 PGK1 SERPINB3 HEBP1 AHNAK SYNE2 GCN1 UTRN VCP RANBP2 HYOU1 NPEPPS UBR4 CAV1 CPOX RFC4 NOP58 SAP30BP EXOC1 HDLBP | 2.45e-09 | 1367 | 230 | 31 | 32687490 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPS2 DNAJB11 MAP2 C9orf78 CD2AP KIF1B NACA NASP PSMD1 PSMD3 PSMD7 PSME1 PLD3 AHNAK USP7 GCN1 AP3D1 DYNC1H1 VCP STRN3 BTF3L4 HYOU1 NPEPPS UBR4 RDX RFC4 IVNS1ABP SEC23IP RPUSD2 TXNDC9 HDLBP PRPS1 | 2.76e-09 | 1455 | 230 | 32 | 22863883 |
| Pubmed | DENND4A NACA PEX1 GIGYF1 CDC40 ZNF638 MICAL3 AP3D1 DIP2B FRAS1 HYOU1 POLE RHOBTB3 POLRMT RDX MORC2 ESF1 ELMO2 GALNT6 AP4B1 DHX34 | 2.91e-09 | 650 | 230 | 21 | 38777146 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | PRPS2 RGPD1 CKAP5 NASP PSMD3 PSMD7 PSME1 SUCLG2 SUCLA2 PGK1 DYNC1H1 RGPD2 RANBP2 HYOU1 NPEPPS UBR4 NOP58 EHHADH EIF4G3 HDLBP PRPS1 | 4.34e-09 | 665 | 230 | 21 | 30457570 |
| Pubmed | VPS13C NACA PEX1 NASP PSMD3 SERPINB3 SYNE2 USP7 ZNF638 CHD6 DMD DYNC1H1 ABCC1 SYNE1 BAZ1B MORC2 RFC4 THAP11 IVNS1ABP INA PCDH9 HDLBP | 7.65e-09 | 754 | 230 | 22 | 35906200 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | GIPC1 DNAJB11 DENND4A KIF1B NASP PSMD1 PSMD3 PSMD7 CLASP2 NUF2 SERPINB3 ASPM USP7 HERC2 GCN1 DYNC1H1 VCP ARMC6 STRN3 RANBP2 HYOU1 NPEPPS POLE UBR4 RFC4 NXN AP4B1 EIF4G3 HDLBP | 9.21e-09 | 1284 | 230 | 29 | 17353931 |
| Pubmed | 9.24e-09 | 12 | 230 | 5 | 14557543 | ||
| Pubmed | SEPTIN9 NACA CLASP2 PLD3 SUCLG2 SUCLA2 PGK1 NGRN CDC40 AHNAK MIEF1 AK4 HERC2 GCN1 AP3D1 DYNC1H1 VCP NPEPPS RDX LRRC40 MORC2 RFC4 VIRMA THAP11 NOP58 EHHADH SAP30BP LSM14B AFF4 HDLBP | 1.02e-08 | 1371 | 230 | 30 | 36244648 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | DNAJB11 KIF1B CKAP5 PSMD1 PSMD3 PSMD7 PGK1 PPP1R37 GCN1 UTRN DYNC1H1 STRN3 HYOU1 SYNE1 UBR4 POMGNT1 CNNM1 SLC4A1AP PHLPP2 | 1.12e-08 | 573 | 230 | 19 | 28330616 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 RPS6KA5 C9orf78 SEPTIN9 KIF1B CKAP5 NASP PSMD1 USP7 ZNF638 MICAL3 DIP2B STRN3 RANBP2 BAZ1B POU2F1 MORC2 VIRMA ESF1 KMT2D SLC4A1AP HDLBP | 1.22e-08 | 774 | 230 | 22 | 15302935 |
| Pubmed | GIPC1 DNAJB11 C9orf78 CD2AP NACA NASP TMOD2 PSMD3 PSMD7 FAM13B PGK1 SERPINB3 AHNAK USP7 DMD GCN1 UTRN DOCK9 POLR2D RDX VIRMA NOP58 INA ELMO2 | 1.22e-08 | 916 | 230 | 24 | 32203420 | |
| Pubmed | SEPTIN9 CKAP5 NASP PSMD1 PSMD3 PSMD7 STK3 AHNAK USP7 GCN1 DYNC1H1 STRN3 RANBP2 UBR4 CAV1 RFC4 | 1.23e-08 | 399 | 230 | 16 | 37536630 | |
| Pubmed | DNAJB11 GIPC2 MYLK SEPTIN9 NACA PSME1 USP7 GCN1 UTRN DYNC1H1 VCP ABCC1 RANBP2 HYOU1 NPEPPS UBR4 RDX NXN NOP58 KMT2D HDLBP | 1.38e-08 | 711 | 230 | 21 | 33022573 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD DENND4A MAP2 CD2AP KIF1B CKAP5 PSMD7 CLASP2 GIGYF1 STK3 AHNAK SYNE2 MIEF1 UTRN DIP2B STIL VIRMA IVNS1ABP INA ELMO2 ANKRD11 SSH2 EIF4G3 | 1.76e-08 | 861 | 230 | 23 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DNAJB11 SEPTIN9 NACA CKAP5 PSMD1 PSMD3 PLD3 PGK1 AHNAK SYNE2 ZNF638 HERC2 GCN1 UTRN DYNC1H1 VCP RANBP2 HYOU1 NPEPPS SYNE1 BAZ1B LRRC40 NOP58 INA HDLBP | 2.37e-08 | 1024 | 230 | 25 | 24711643 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SEPTIN9 PSMD1 PSMD3 FYCO1 PSME1 PGK1 GUF1 AHNAK USP7 SAMM50 GCN1 UTRN AP3D1 DYNC1H1 VCP HYOU1 NPEPPS SYNE1 UBR4 NOP58 HDLBP PRPS1 | 2.56e-08 | 807 | 230 | 22 | 30575818 |
| Pubmed | SEPTIN9 CKAP5 GIGYF1 ZNF638 GCN1 UTRN FAM135A AP3D1 RANBP2 HYOU1 AP4E1 SEC23IP TRIM13 | 2.63e-08 | 263 | 230 | 13 | 34702444 | |
| Pubmed | MRPL12 SEPTIN9 CD2AP KIF1B NACA CKAP5 NASP PSMD1 AHNAK USP7 DMD GCN1 AP3D1 DYNC1H1 VCP POLRMT CHD9 RFC4 NOP58 EXOC1 HDLBP PRPS1 | 2.67e-08 | 809 | 230 | 22 | 32129710 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | PRPS2 NASP PSMD1 PSME1 PGK1 AHNAK GCN1 DYNC1H1 VCP RANBP2 NPEPPS CAV1 CPS1 IVNS1ABP NOP58 PRPS1 | 2.69e-08 | 422 | 230 | 16 | 27342126 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | CD2AP RGPD1 CKAP5 CLASP2 ZNF638 UTP3 GCN1 CDCA7L DYNC1H1 VCP RGPD2 RANBP2 LRRC40 VIRMA EIF4G3 | 3.09e-08 | 370 | 230 | 15 | 22922362 |
| Pubmed | MRPL12 NACA PSMD1 PSMD3 PSMD7 CLASP2 AHNAK USP7 TSR3 AP3D1 HYOU1 POLRMT ESF1 THAP11 GLMN LSM14B DHX34 HDLBP | 3.11e-08 | 547 | 230 | 18 | 37267103 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | CKAP5 NASP PSMD1 SERPINB3 USP7 VCP RANBP2 HYOU1 NPEPPS CPS1 HDLBP | 3.48e-08 | 179 | 230 | 11 | 36261009 |
| Pubmed | GIPC1 SEPTIN9 NACA CKAP5 PSMD1 PSMD3 PSMD7 PGK1 AHNAK USP7 GCN1 VCP HYOU1 NPEPPS CHD9 CPOX SEC23IP | 4.00e-08 | 494 | 230 | 17 | 26831064 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | PRPS2 DNAJB11 PSMD1 PSMD3 SUCLG2 SUCLA2 PRPS1L1 STK3 USP7 SAMM50 CRYZL1 DYNC1H1 VCP NPEPPS CPS1 RFC4 NOP58 INA | 5.06e-08 | 565 | 230 | 18 | 33567341 |
| Pubmed | SEPTIN9 CD2AP KIF1B CKAP5 PSMD1 PSMD3 AHNAK MICAL3 GCN1 FAM135A AP3D1 DYNC1H1 VCP RANBP2 HYOU1 RDX LRRC40 SEC23IP EIF4G3 HDLBP | 6.41e-08 | 708 | 230 | 20 | 39231216 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CYLD VPS13C SEPTIN9 BACH2 CD2AP KIF1B RGPD1 CKAP5 PSME1 MICAL3 HERC2 DYNC1H1 STRN3 RANBP2 BTF3L4 HYOU1 STIL AP4E1 GLMN INA ELMO2 AP4B1 | 6.73e-08 | 853 | 230 | 22 | 28718761 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DNAJB11 MAP2 PLD3 CDC40 PCDH15 USP7 ZNF638 CHD6 TSR3 GCN1 AP3D1 DYNC1H1 VCP DIP2B RANBP2 BTF3L4 SYNE1 POLR2D CHD9 RFC4 THAP11 NOP58 INA AFF4 PROX1 | 6.83e-08 | 1082 | 230 | 25 | 38697112 |
| Pubmed | GIPC1 GIPC2 MRPL12 CD2AP NACA CKAP5 CLASP2 GUF1 GORAB USP7 CHD6 UTP3 HERC2 UTRN STRN3 RANBP2 BTF3L4 SYNE1 POLRMT BAZ1B MORC2 VIRMA ESF1 SLC4A1AP SAP30BP ANKRD11 EIF4G3 LSM14B AFF4 HDLBP | 7.10e-08 | 1497 | 230 | 30 | 31527615 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD1 TMOD2 PSMD1 PSMD3 PSMD7 PLD3 SUCLG2 SUCLA2 PGK1 AHNAK DYNC1H1 VCP RGPD2 RANBP2 HYOU1 NPEPPS UBR4 RDX CAV1 | 7.61e-08 | 647 | 230 | 19 | 26618866 |
| Pubmed | CYLD DNAJB11 ATP7B BACH2 PEX1 GIGYF1 ACY1 ASPM USP7 TSR3 VCP NOVA2 ARMC6 RHOBTB3 POLRMT BAZ1B CHD9 CAV1 RFC4 LRIG3 ZFHX4 SAP30BP DHX34 AFF4 PROX1 | 1.23e-07 | 1116 | 230 | 25 | 31753913 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DNAJB11 RPS6KA5 SEPTIN9 CLASP2 PGK1 PHKA1 CHD6 HERC2 AP3D1 VCP DIP2B RANBP2 UBR4 RDX MORC2 HDLBP | 1.36e-07 | 475 | 230 | 16 | 31040226 |
| Pubmed | 2.24e-07 | 215 | 230 | 11 | 35973513 | ||
| Pubmed | 2.29e-07 | 9 | 230 | 4 | 9733766 | ||
| Pubmed | DENND4A KIF1B PSMD1 CLASP2 SUCLG2 SYNE2 UTRN VCP RANBP2 SYNE1 DOCK9 RDX DGKD IVNS1ABP EXOC1 MYBPC2 | 2.49e-07 | 497 | 230 | 16 | 23414517 | |
| Pubmed | DNAJB11 PSMD1 PLD3 SUCLA2 AK4 SAMM50 CARS2 AP3D1 ARMC6 HYOU1 UBR4 LRRC40 RFC4 | 2.84e-07 | 323 | 230 | 13 | 24797263 | |
| Pubmed | 2.85e-07 | 3 | 230 | 3 | 1314091 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 4.17e-07 | 182 | 230 | 10 | 31067453 | |
| Pubmed | DNAJB11 PSMD7 SUCLG2 SUCLA2 HERC2 DYNC1H1 VCP RANBP2 HYOU1 POLE UBR4 VIRMA IVNS1ABP CTNNA3 AFF4 | 4.67e-07 | 457 | 230 | 15 | 22190034 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CKAP5 PSMD1 PSMD3 PLD3 PGK1 USP7 GCN1 DYNC1H1 DIP2B NPEPPS UBR4 RDX CPS1 | 5.79e-07 | 344 | 230 | 13 | 30333137 |
| Pubmed | DNAJB11 CKAP5 PSMD1 SUCLG2 SUCLA2 AK4 CARS2 GCN1 DYNC1H1 VCP RANBP2 HYOU1 UBR4 LRRC40 RFC4 HDLBP | 6.44e-07 | 534 | 230 | 16 | 35032548 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPS2 NACA NASP PSMD3 PSMD7 SUCLG2 SUCLA2 GUF1 CDC40 AHNAK CHD6 GCN1 AP3D1 DYNC1H1 ARMC6 RANBP2 HYOU1 UBR4 BAZ1B RDX LRRC40 THAP11 NOP58 SAP30BP TXNDC9 PRPS1 | 7.64e-07 | 1318 | 230 | 26 | 30463901 |
| Pubmed | 8.09e-07 | 151 | 230 | 9 | 17043677 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CYLD GPRASP1 PSMD1 PSMD3 PSMD7 CLASP2 SUCLG2 SUCLA2 USP7 HERC2 GCN1 UTRN VCP STRN3 NPEPPS RDX RFC4 NXN CCNA2 IVNS1ABP EIF4G3 PHLPP2 | 1.07e-06 | 1005 | 230 | 22 | 19615732 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPS2 SEPTIN9 NACA CKAP5 PSMD3 PGK1 CDC40 SERPINB3 AHNAK USP7 ZNF638 SAMM50 UTP3 DYNC1H1 HYOU1 POLRMT BAZ1B CAV1 RFC4 VIRMA ESF1 NOP58 SAP30BP LSM14B HDLBP | 1.09e-06 | 1257 | 230 | 25 | 36526897 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.14e-06 | 4 | 230 | 3 | 10469592 | |
| Pubmed | 1.14e-06 | 4 | 230 | 3 | 7983737 | ||
| Pubmed | C9orf78 SEPTIN9 CKAP5 PSMD1 PSMD3 ME2 PTPN9 CDCA7L DYNC1H1 NPEPPS LRRC40 THAP11 GLMN ELMO2 SEC23IP EXOC1 | 1.20e-06 | 560 | 230 | 16 | 35241646 | |
| Pubmed | GIPC1 PSMD3 PSME1 PGK1 AHNAK USP7 CDCA7L VCP RANBP2 BTF3L4 POLE UBR4 POLR2D BAZ1B CHD9 CAV1 MORC2 RFC4 VIRMA ESF1 CCNA2 NOP58 | 1.24e-06 | 1014 | 230 | 22 | 32416067 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SEPTIN9 PSMD3 SUCLG2 SUCLA2 GCN1 AP3D1 DYNC1H1 RANBP2 POLE UBR4 POLRMT BAZ1B CPS1 MORC2 RFC4 VIRMA NOP58 EIF4G3 | 1.25e-06 | 704 | 230 | 18 | 29955894 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | CD2AP NACA CKAP5 NASP AHNAK ASPM GCN1 AP3D1 DYNC1H1 RANBP2 HDLBP | 1.26e-06 | 256 | 230 | 11 | 33397691 |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.35e-06 | 119 | 230 | 8 | 35776542 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MAP2 SEPTIN9 TMOD2 PSMD3 AHNAK SYNE2 CARS2 GCN1 DIP2B UBR4 RDX INA EIF4G3 HDLBP PRPS1 | 1.36e-06 | 498 | 230 | 15 | 36634849 |
| Pubmed | CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 USP7 SAMM50 GCN1 AP3D1 DYNC1H1 VCP RANBP2 HYOU1 UBR4 LRRC40 NOP58 SEC23IP | 1.43e-06 | 638 | 230 | 17 | 33239621 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.44e-06 | 120 | 230 | 8 | 31413325 | |
| Pubmed | SEPTIN9 FYCO1 PGK1 FREM1 STK3 TECPR2 USP7 GCN1 UTRN DIP2B NPEPPS RUBCNL POLRMT INA | 1.51e-06 | 437 | 230 | 14 | 20562859 | |
| Pubmed | 1.54e-06 | 210 | 230 | 10 | 16565220 | ||
| Pubmed | PRPS2 DNAJB11 GIPC2 FYCO1 PGK1 AHNAK SAMM50 AP3D1 HYOU1 UBR4 RDX CAV1 SSH2 HDLBP PRPS1 | 1.54e-06 | 503 | 230 | 15 | 36217030 | |
| Pubmed | MRPL12 SEPTIN9 PEX1 NASP TMOD2 PSMD7 PGK1 ASPM USP7 UTRN DYNC1H1 VCP ESF1 SLC4A1AP SAP30BP | 1.66e-06 | 506 | 230 | 15 | 30890647 | |
| Pubmed | SEPTIN9 CKAP5 PSMD1 PSMD3 PSMD7 CLASP2 GIGYF1 SERPINB3 NBEAL2 SAMM50 GCN1 VCP | 1.72e-06 | 320 | 230 | 12 | 28685749 | |
| Pubmed | 1.74e-06 | 86 | 230 | 7 | 37253089 | ||
| Pubmed | NACA NASP PSMD1 PSMD3 PSMD7 SUCLG2 SUCLA2 AK4 GCN1 DYNC1H1 VCP ABCC1 HYOU1 NPEPPS CPOX RFC4 PREP SEC23IP TXNDC9 PRPS1 | 1.86e-06 | 878 | 230 | 20 | 37223481 | |
| Pubmed | 1.88e-06 | 87 | 230 | 7 | 12465718 | ||
| Pubmed | CD2AP CKAP5 PSMD3 AHNAK USP7 VCP RANBP2 LRRC40 SAP30BP TXNDC9 HDLBP | 1.89e-06 | 267 | 230 | 11 | 33417871 | |
| Pubmed | 1.96e-06 | 125 | 230 | 8 | 29467281 | ||
| Pubmed | NACA CKAP5 PSMD1 PSMD7 PLD3 SAMM50 HERC2 GCN1 VCP ARMC6 RANBP2 UBR4 CAV1 IVNS1ABP GLMN ELMO2 IPO13 | 2.12e-06 | 657 | 230 | 17 | 36180527 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DNAJB11 CKAP5 PSMD1 PSMD3 PSMD7 PTPN9 DMD GCN1 UTRN VCP DIP2B RANBP2 HYOU1 NPEPPS POLE UBR4 POLRMT CPOX PREP TXNDC9 PRPS1 | 2.41e-06 | 974 | 230 | 21 | 28675297 |
| Pubmed | Defining human ERAD networks through an integrative mapping strategy. | 2.50e-06 | 173 | 230 | 9 | 22119785 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | CKAP5 PGK1 AHNAK USP7 ZNF638 GCN1 DYNC1H1 DIP2B RANBP2 UBR4 RFC4 HDLBP | 2.51e-06 | 332 | 230 | 12 | 32786267 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 2.75e-06 | 175 | 230 | 9 | 25756610 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.83e-06 | 5 | 230 | 3 | 12629516 | |
| Pubmed | 2.83e-06 | 5 | 230 | 3 | 29744875 | ||
| Pubmed | 2.83e-06 | 5 | 230 | 3 | 18396275 | ||
| Pubmed | 2.95e-06 | 93 | 230 | 7 | 27215380 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.17e-06 | 94 | 230 | 7 | 21542922 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NACA CKAP5 PSMD3 CDC40 ASPM UTP3 HERC2 GCN1 AP3D1 POLE POLRMT BAZ1B RFC4 VIRMA ESF1 THAP11 NOP58 EIF4G3 | 3.56e-06 | 759 | 230 | 18 | 35915203 |
| Pubmed | 3.89e-06 | 63 | 230 | 6 | 19193609 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 4.20e-06 | 235 | 230 | 10 | 28378594 | |
| Interaction | HSPH1 interactions | CYLD C9orf78 NACA LRRK2 CKAP5 PSMD1 PSMD3 PSMD7 HPSE PGK1 USP7 ZNF638 UTRN DYNC1H1 VCP RDX STIL CPOX CPS1 VIRMA SLC4A1AP PREP EIF4G3 PHLPP2 | 2.20e-10 | 448 | 224 | 24 | int:HSPH1 |
| Interaction | BAP1 interactions | PRPS2 GIPC1 DNAJB11 MRPL12 SEPTIN9 CD2AP NACA CKAP5 NASP PSMD1 PSMD3 PSMD7 CLASP2 PSME1 PGK1 PHKA1 AHNAK USP7 MICAL3 GCN1 AP3D1 DYNC1H1 VCP STRN3 RANBP2 HYOU1 NPEPPS UBR4 RDX CPS1 RFC4 ESF1 IVNS1ABP NOP58 INA PREP EIF4G3 LSM14B HDLBP PRPS1 | 5.22e-09 | 1314 | 224 | 40 | int:BAP1 |
| Interaction | FBXO22 interactions | CYLD BDP1 DCHS2 MAP2 SEPTIN9 NASP PSMD7 CLASP2 RYR3 NBEAL2 USP7 MICAL3 UTP3 AP3D1 DPYD NPEPPS DOCK9 POLRMT CHD9 MORC2 SLC4A1AP SAP30BP ANKRD11 | 4.03e-08 | 540 | 224 | 23 | int:FBXO22 |
| Interaction | SIRT7 interactions | CKAP5 PSMD1 ME2 PGK1 AHNAK SYNE2 USP7 ZNF638 HERC2 GCN1 UTRN DYNC1H1 VCP RANBP2 HYOU1 NPEPPS POLE UBR4 POLRMT BAZ1B VIRMA ESF1 NOP58 INA PREP EIF4G3 HDLBP | 6.87e-08 | 744 | 224 | 27 | int:SIRT7 |
| Interaction | TRIM33 interactions | CYLD C9orf78 CKAP5 NASP PSMD1 ACY1 SERPINB3 USP7 VCP RANBP2 HYOU1 NPEPPS CAV1 CPS1 RFC4 VIRMA CCNA2 CRYAA HDLBP ZNF44 | 1.83e-07 | 453 | 224 | 20 | int:TRIM33 |
| Interaction | PSMB6 interactions | CYLD LRRK2 PSMD1 PSMD3 PSMD7 PSME1 USP7 CARS2 VCP VIRMA CRYAA SEC23IP EIF4G3 HDLBP | 6.09e-07 | 243 | 224 | 14 | int:PSMB6 |
| Interaction | BRCA1 interactions | GIPC1 DNAJB11 SEPTIN9 KIF1B NACA CKAP5 PSMD1 PSMD3 PSMD7 PGK1 AHNAK USP7 CRYZL1 HERC2 GCN1 DYNC1H1 VCP ABCC1 HYOU1 NPEPPS POLE UBR4 POLR2D POMGNT1 RDX POU2F1 CHD9 CPOX RFC4 CCNA2 CCNE1 PREP SEC23IP HDLBP | 1.15e-06 | 1249 | 224 | 34 | int:BRCA1 |
| Interaction | KCNA3 interactions | SEPTIN9 CD2AP KIF1B NACA LRRK2 CKAP5 PSMD1 PSMD3 FYCO1 AHNAK MICAL3 GCN1 FAM135A AP3D1 DYNC1H1 VCP RANBP2 HYOU1 RDX CHD9 LRRC40 CAV1 MORC2 SEC23IP CTNNA3 EIF4G3 HDLBP | 1.51e-06 | 871 | 224 | 27 | int:KCNA3 |
| Interaction | KIF5B interactions | PRPS2 DNAJB11 PSMD1 PSMD3 PSMD7 FYCO1 PSME1 HERC2 DYNC1H1 RANBP2 NPEPPS GRIA1 VIRMA SEC23IP EXOC1 HDLBP | 1.91e-06 | 348 | 224 | 16 | int:KIF5B |
| Interaction | STIP1 interactions | LRRK2 CKAP5 NASP PSMD1 PSMD3 PSMD7 CLASP2 HPSE PGK1 PTPN9 AHNAK USP7 SAMM50 GCN1 AP3D1 DYNC1H1 VCP RANBP2 EVC2 HYOU1 UBR4 RDX POU2F1 LRRC40 STIL VIRMA TXNIP NOP58 SEC23IP | 2.55e-06 | 1006 | 224 | 29 | int:STIP1 |
| Interaction | NAA40 interactions | MRPL12 SEPTIN9 NACA CKAP5 NASP PSMD7 ME2 PGK1 AHNAK USP7 ZNF638 GCN1 UTRN AP3D1 VCP STRN3 RANBP2 BTF3L4 BAZ1B RDX RFC4 ESF1 SAP30BP SEC23IP TXNDC9 EIF4G3 AFF4 HDLBP | 4.40e-06 | 978 | 224 | 28 | int:NAA40 |
| Interaction | DRP2 interactions | 4.61e-06 | 11 | 224 | 4 | int:DRP2 | |
| Interaction | PHLPP1 interactions | PRPS2 CD2AP NACA CKAP5 NASP AHNAK ASPM GCN1 AP3D1 DYNC1H1 RANBP2 VIRMA GLMN PHLPP2 HDLBP | 5.16e-06 | 333 | 224 | 15 | int:PHLPP1 |
| Interaction | EGLN3 interactions | CYLD DNAJB11 DENND4A CKAP5 PEX1 NASP PSMD1 PSMD3 PSMD7 NUF2 GIGYF1 SUCLG2 SUCLA2 STK3 ASPM USP7 SAMM50 GCN1 UTRN FAM135A AP3D1 DYNC1H1 VCP ARMC6 RANBP2 NPEPPS POLE UBR4 LRRC40 STIL GLMN ANKRD11 TXNDC9 | 7.02e-06 | 1296 | 224 | 33 | int:EGLN3 |
| Interaction | CALM1 interactions | CYLD DENND4A MYLK VPS13C KIF1B NACA LRRK2 PGK1 PHKA1 SYNE2 ASPM HERC2 UTRN STRN3 RANBP2 UBR4 POLRMT RDX CCNA2 CCNE1 TRIM13 | 7.27e-06 | 626 | 224 | 21 | int:CALM1 |
| Interaction | PSMD14 interactions | CYLD GIPC2 PSMD1 PSMD3 PSMD7 PSME1 SUCLA2 GUF1 SYNE2 CHD6 HERC2 VCP UBR4 PCDH11Y CAV1 VIRMA LRIG3 INA PREP | 7.37e-06 | 527 | 224 | 19 | int:PSMD14 |
| Interaction | STRN interactions | GIPC1 FILIP1 PSMD3 STK3 AHNAK DYNC1H1 STRN3 CAV1 VIRMA EXOC1 | 8.96e-06 | 154 | 224 | 10 | int:STRN |
| Interaction | PSMD13 interactions | CYLD RPS6KA5 MAP2 C9orf78 PSMD1 PSMD3 PSMD7 PSME1 DYNC1H1 VCP STRN3 UBR4 VIRMA PREP | 8.99e-06 | 306 | 224 | 14 | int:PSMD13 |
| Interaction | PSMD11 interactions | CYLD LRRK2 PSMD1 PSMD3 PSMD7 PSME1 HERC2 DYNC1H1 VCP POLE RDX CPOX VIRMA SLC4A1AP EIF4G3 | 1.04e-05 | 353 | 224 | 15 | int:PSMD11 |
| Interaction | ACTC1 interactions | MYLK MRPL12 SEPTIN9 CD2AP PEX1 NASP TMOD2 PSMD7 PGK1 SYNE2 ASPM USP7 DMD UTRN DYNC1H1 WNK2 VCP SYNE1 VIRMA ESF1 SLC4A1AP SAP30BP | 1.06e-05 | 694 | 224 | 22 | int:ACTC1 |
| Interaction | RCOR1 interactions | C9orf78 CD2AP CKAP5 PSMD1 NUF2 AHNAK CHD6 GCN1 UTRN VCP RANBP2 UBR4 POLRMT VIRMA THAP11 CRYAA KMT2D ZFHX4 | 1.12e-05 | 494 | 224 | 18 | int:RCOR1 |
| Interaction | DOCK10 interactions | 1.29e-05 | 28 | 224 | 5 | int:DOCK10 | |
| Interaction | RAB5A interactions | PRPS2 GIPC1 LRRK2 CKAP5 PLD3 PGK1 TECPR2 SYNE2 PPP1R37 HERC2 STX17 FAM135A DYNC1H1 UBR4 POLRMT CAV1 VIRMA TXNIP SEC23IP TRIM13 HDLBP PRPS1 | 1.39e-05 | 706 | 224 | 22 | int:RAB5A |
| Interaction | PSMD4 interactions | PRPS2 CYLD LRRK2 PSMD1 PSMD3 PSMD7 PSME1 USP7 MICAL3 CARS2 VCP POLE VIRMA CCNA2 TXNIP | 1.69e-05 | 368 | 224 | 15 | int:PSMD4 |
| Interaction | SNCA interactions | MAP2 VPS13C SEPTIN9 LRRK2 TMOD2 PSMD3 AHNAK SYNE2 USP7 GCN1 DYNC1H1 DIP2B UBR4 RDX CAV1 VIRMA INA PREP SAP30BP EIF4G3 HDLBP PRPS1 | 1.72e-05 | 716 | 224 | 22 | int:SNCA |
| Interaction | PSMB5 interactions | CYLD LRRK2 PSMD1 PSMD3 PSMD7 PSME1 USP7 DYNC1H1 VCP RDX VIRMA TXNIP | 1.80e-05 | 242 | 224 | 12 | int:PSMB5 |
| Interaction | PPP2R1A interactions | C9orf78 NACA LRRK2 PEX1 PSMD1 PSMD3 PSMD7 DGKH PSME1 FAM13B CDC40 USP7 DYNC1H1 VCP STRN3 RDX CAV1 VIRMA TXNIP SLC4A1AP LSM14B | 1.80e-05 | 665 | 224 | 21 | int:PPP2R1A |
| Interaction | PSMD12 interactions | BDP1 RPS6KA5 NASP PSMD1 PSMD3 PSMD7 PSME1 PTPN9 VCP RDX CAV1 RFC4 VIRMA HDLBP | 2.16e-05 | 331 | 224 | 14 | int:PSMD12 |
| Interaction | PSMB8 interactions | 2.27e-05 | 105 | 224 | 8 | int:PSMB8 | |
| Interaction | MYLK interactions | 2.43e-05 | 106 | 224 | 8 | int:MYLK | |
| Interaction | CENPE interactions | 2.43e-05 | 106 | 224 | 8 | int:CENPE | |
| Interaction | LIMA1 interactions | DENND4A C9orf78 SEPTIN9 LRRK2 PSMD1 GIGYF1 AHNAK USP7 ZNF638 UTRN RDX CAV1 VIRMA CRYAA SSH2 EIF4G3 | 2.63e-05 | 429 | 224 | 16 | int:LIMA1 |
| Interaction | FHIP1A interactions | 2.99e-05 | 33 | 224 | 5 | int:FHIP1A | |
| Interaction | FBXL6 interactions | MRPL12 NACA PSMD1 PSMD3 PSMD7 CLASP2 AHNAK USP7 TSR3 AP3D1 HYOU1 POLRMT ESF1 CCNA2 THAP11 GLMN LSM14B DHX34 HDLBP | 2.99e-05 | 583 | 224 | 19 | int:FBXL6 |
| Interaction | PHF21A interactions | CKAP5 PSMD1 NUF2 AHNAK CHD6 UTRN RANBP2 UBR4 POLRMT THAP11 KMT2D ZFHX4 SEC23IP EXOC1 | 3.20e-05 | 343 | 224 | 14 | int:PHF21A |
| Interaction | PPIB interactions | CYLD DNAJB11 GANC NACA LRRK2 PGK1 UTRN VCP HYOU1 CPS1 VIRMA SLC5A5 SYNE3 AP4B1 | 3.41e-05 | 345 | 224 | 14 | int:PPIB |
| Interaction | SUMO2 interactions | NACA LRRK2 CKAP5 PGK1 AHNAK USP7 ZNF638 GCN1 DYNC1H1 VCP DIP2B RANBP2 UBR4 BAZ1B CAV1 RFC4 NOP58 ZMYM5 HDLBP | 3.60e-05 | 591 | 224 | 19 | int:SUMO2 |
| Interaction | TOP3B interactions | KIF1B CLASP2 FYCO1 NBEAL2 AHNAK USP7 C19orf44 MICAL3 HERC2 TSR3 GCN1 AP3D1 DYNC1H1 WNK2 GAREM1 FRAS1 HYOU1 POLE DOCK9 UBR4 POLRMT POMGNT1 RGS16 THAP11 CCNE1 KMT2D SYNE3 CELSR3 RALGPS1 SBF2 ANKRD11 LSM14B DHX34 HDLBP | 3.70e-05 | 1470 | 224 | 34 | int:TOP3B |
| Interaction | PSMD8 interactions | 3.81e-05 | 182 | 224 | 10 | int:PSMD8 | |
| Interaction | VPS53 interactions | 3.82e-05 | 146 | 224 | 9 | int:VPS53 | |
| Interaction | YWHAH interactions | CYLD DENND4A MAP2 CD2AP KIF1B LRRK2 CKAP5 PSMD7 CLASP2 GIGYF1 STK3 AHNAK SYNE2 ZNF638 MIEF1 UTRN WNK2 VCP DIP2B EVC2 DOCK9 STIL VIRMA IVNS1ABP INA ANKRD11 SSH2 EIF4G3 | 3.88e-05 | 1102 | 224 | 28 | int:YWHAH |
| Interaction | GSK3B interactions | PRPS2 GIPC1 CYLD DENND4A SEPTIN9 NACA LRRK2 RGPD1 PSMD1 CLASP2 DEFA1 USP7 MICAL3 CHD6 HERC2 UTRN VCP NPEPPS CAV1 CCNE1 SYNE3 INA SAP30BP DHX34 | 3.89e-05 | 868 | 224 | 24 | int:GSK3B |
| Interaction | CYLD interactions | GIPC1 CYLD DNAJB11 MRPL12 SEPTIN9 CKAP5 PSMD1 PSMD3 FYCO1 PGK1 SERPINB3 AHNAK HERC2 GCN1 DYNC1H1 VCP HYOU1 UBR4 GRIA1 RFC4 VIRMA IVNS1ABP SYNE3 SLC4A1AP | 3.89e-05 | 868 | 224 | 24 | int:CYLD |
| Interaction | PSMA6 interactions | CYLD KIF1B LRRK2 PSMD1 PSMD3 PSMD7 PSME1 PGK1 VCP VIRMA CCNA2 CCNE1 RTP5 | 3.94e-05 | 305 | 224 | 13 | int:PSMA6 |
| Interaction | CFTR interactions | DNAJB11 SEPTIN9 RGPD1 TMOD2 PSMD1 PSMD3 PSMD7 PLD3 SUCLG2 SUCLA2 PGK1 RYR3 DEFA3 SERPINB3 AHNAK DMD GCN1 AP3D1 DYNC1H1 VCP GAREM1 RGPD2 RANBP2 B3GNT9 HYOU1 NPEPPS POLE UBR4 RDX CAV1 NRIP3 THAP11 UNC45B HDLBP | 4.24e-05 | 1480 | 224 | 34 | int:CFTR |
| Interaction | SEPTIN9 interactions | CYLD MYLK MRPL12 C9orf78 SEPTIN9 CD2AP SUCLG2 VCP RDX CAV1 VIRMA LSM14B | 4.37e-05 | 265 | 224 | 12 | int:SEPTIN9 |
| Interaction | ITGB1 interactions | CYLD CKAP5 PSMD1 PLD3 GCN1 DYNC1H1 VCP DIP2B UBR4 RDX CHD9 CAV1 CPS1 VIRMA SYNE3 | 4.43e-05 | 400 | 224 | 15 | int:ITGB1 |
| Interaction | ZFYVE1 interactions | 4.86e-05 | 59 | 224 | 6 | int:ZFYVE1 | |
| Interaction | HERC2 interactions | CYLD MRPL12 LRRK2 PEX1 PSMD1 NUF2 PHKA1 SYNE2 ASPM HERC2 AP3D1 UBR4 VIRMA TXNIP KMT2D SEC23IP HDLBP | 5.07e-05 | 503 | 224 | 17 | int:HERC2 |
| Interaction | METTL14 interactions | DNAJB11 NACA CKAP5 NASP PSMD1 PSMD3 RYR3 DEFA3 AHNAK USP7 GCN1 VCP ERICH3 CPS1 VIRMA NOP58 CELSR3 HDLBP | 5.56e-05 | 558 | 224 | 18 | int:METTL14 |
| Interaction | RAB4A interactions | DENND4A ATP7B VPS13C CD2AP KIF1B ACY1 PTPN9 SYNE2 PPP1R37 FAM135A AP3D1 SYNE1 CAV1 AP4E1 SEC23IP TRIM13 | 5.60e-05 | 457 | 224 | 16 | int:RAB4A |
| Interaction | STXBP1 interactions | 5.73e-05 | 191 | 224 | 10 | int:STXBP1 | |
| Interaction | CTNNB1 interactions | CYLD LRRK2 PSMD1 PSMD7 PGK1 SYNE2 ASPM USP7 CHD6 HERC2 UTRN DYNC1H1 VCP ABCC1 STRN3 RANBP2 CAV1 RET VIRMA CCNA2 CCNE1 KMT2D CTNNA3 CDH6 CDH12 HDLBP | 5.94e-05 | 1009 | 224 | 26 | int:CTNNB1 |
| Interaction | ACTR1A interactions | CYLD NASP PSMD1 CLASP2 DYNC1H1 VCP POLR2D VIRMA GLMN EHHADH TXNDC9 SSH2 | 6.03e-05 | 274 | 224 | 12 | int:ACTR1A |
| Interaction | MOB3C interactions | SEPTIN9 CKAP5 NASP PSMD1 PSMD3 PSMD7 AHNAK USP7 GCN1 DYNC1H1 RANBP2 UBR4 CAV1 RFC4 | 6.09e-05 | 364 | 224 | 14 | int:MOB3C |
| Interaction | S100A2 interactions | DENND4A CKAP5 DGKH PPP1R37 MICAL3 SYNE1 POLRMT RDX POU2F1 STIL THAP11 KMT2D PCIF1 DHX34 PROX1 | 6.19e-05 | 412 | 224 | 15 | int:S100A2 |
| Interaction | EFTUD2 interactions | PRPS2 CYLD MRPL12 C9orf78 SEPTIN9 NACA CKAP5 PSMD1 PSMD3 CLASP2 PSME1 CDC40 AHNAK SYNE2 USP7 ZNF638 CARS2 GCN1 AP3D1 DYNC1H1 VCP RANBP2 BTF3L4 UBR4 RDX LRRC40 CPS1 RFC4 VIRMA NOP58 RPUSD2 HDLBP PRPS1 | 6.60e-05 | 1449 | 224 | 33 | int:EFTUD2 |
| Interaction | PPP1R12A interactions | MYLK C9orf78 SEPTIN9 NACA LRRK2 AHNAK USP7 VCP STRN3 RANBP2 RDX CPOX VIRMA | 6.86e-05 | 322 | 224 | 13 | int:PPP1R12A |
| Interaction | BAG2 interactions | CYLD DNAJB11 VPS13C LRRK2 CKAP5 PEX1 HPSE AHNAK VCP EVC2 POLE POU2F1 LRRC40 CAV1 STIL VIRMA SLC5A5 EIF4G3 HDLBP | 7.12e-05 | 622 | 224 | 19 | int:BAG2 |
| Interaction | EMC1 interactions | DNAJB11 NASP PSMD1 PLD3 AHNAK GCN1 DYNC1H1 VCP RANBP2 NPEPPS CAV1 RET CPS1 VIRMA SYNE3 | 7.28e-05 | 418 | 224 | 15 | int:EMC1 |
| Interaction | SRGAP2 interactions | PRPS2 DENND4A KIF1B GIGYF1 SYNE2 ZNF638 HERC2 VIRMA IVNS1ABP EXOC1 | 7.42e-05 | 197 | 224 | 10 | int:SRGAP2 |
| Interaction | KCTD13 interactions | GPRASP1 MAP2 SEPTIN9 KIF1B CKAP5 TMOD2 PSMD3 CLASP2 PLD3 SUCLA2 PGK1 USP7 MICAL3 SAMM50 DMD UTRN AP3D1 DYNC1H1 WNK2 VCP STRN3 HYOU1 NPEPPS SYNE1 RDX GRIA1 VIRMA INA EXOC1 SSH2 EIF4G3 HDLBP | 7.43e-05 | 1394 | 224 | 32 | int:KCTD13 |
| Interaction | PCNT interactions | PRPS2 SEPTIN9 SAMM50 UTRN SYNE1 RDX STIL VIRMA SYNE3 EXOC1 EIF4G3 | 8.49e-05 | 241 | 224 | 11 | int:PCNT |
| Interaction | SEM1 interactions | 8.56e-05 | 162 | 224 | 9 | int:SEM1 | |
| Interaction | PDIA3 interactions | DNAJB11 MRPL12 SEPTIN9 LRRK2 PSME1 PLD3 PGK1 SERPINB3 AHNAK CARS2 VCP NPEPPS CAV1 VIRMA SYNE3 HDLBP | 9.02e-05 | 476 | 224 | 16 | int:PDIA3 |
| Interaction | HDAC4 interactions | DNAJB11 DENND4A RPS6KA5 SEPTIN9 CLASP2 GIGYF1 PGK1 PHKA1 ZNF638 CHD6 HERC2 AP3D1 VCP DIP2B RANBP2 UBR4 RDX MORC2 VIRMA ANKRD11 HDLBP | 9.08e-05 | 744 | 224 | 21 | int:HDAC4 |
| Interaction | TES interactions | PSMD3 SUCLA2 GCN1 UTRN DYNC1H1 VCP ARMC6 RANBP2 UBR4 RDX RET CPS1 RFC4 | 9.33e-05 | 332 | 224 | 13 | int:TES |
| Interaction | AARS2 interactions | MRPL12 C9orf78 SUCLG2 SUCLA2 ME2 NGRN GUF1 AK4 CARS2 NDUFAF5 POLRMT VIRMA EHHADH | 9.91e-05 | 334 | 224 | 13 | int:AARS2 |
| Interaction | FOXP3 interactions | CD2AP CKAP5 CLASP2 USP7 ZNF638 UTP3 GCN1 CDCA7L DYNC1H1 VCP NOVA2 RANBP2 LRRC40 VIRMA EIF4G3 | 1.05e-04 | 432 | 224 | 15 | int:FOXP3 |
| Interaction | STARD13 interactions | 1.09e-04 | 68 | 224 | 6 | int:STARD13 | |
| Interaction | PSMC5 interactions | CYLD MAP2 BACH2 CD2AP PSMD1 PSMD3 PSMD7 PSME1 ASPM DYNC1H1 VCP ABCC1 UBR4 VIRMA THAP11 SLC4A1AP | 1.09e-04 | 484 | 224 | 16 | int:PSMC5 |
| Interaction | ANKZF1 interactions | 1.11e-04 | 43 | 224 | 5 | int:ANKZF1 | |
| Interaction | PHKA1 interactions | 1.11e-04 | 43 | 224 | 5 | int:PHKA1 | |
| Interaction | CTDP1 interactions | 1.12e-04 | 207 | 224 | 10 | int:CTDP1 | |
| Interaction | RICTOR interactions | SEPTIN9 CD2AP NACA RGPD1 CKAP5 NASP PSMD3 AHNAK GCN1 UTRN DYNC1H1 VCP RGPD2 STRN3 HYOU1 RDX CAV1 CPS1 VIRMA SEC23IP HDLBP | 1.20e-04 | 759 | 224 | 21 | int:RICTOR |
| Interaction | PSME2 interactions | 1.22e-04 | 133 | 224 | 8 | int:PSME2 | |
| Interaction | B3GNT2 interactions | DNAJB11 CKAP5 PSMD3 PGK1 APOM DEFA3 SERPINB3 AHNAK SAMM50 HERC2 GCN1 ARMC6 B3GNT9 HYOU1 CPS1 SEC23IP IPO13 | 1.26e-04 | 542 | 224 | 17 | int:B3GNT2 |
| Interaction | DLST interactions | CYLD MRPL12 C9orf78 CKAP5 SUCLA2 PGK1 NGRN USP7 AK4 AP3D1 DYNC1H1 HYOU1 VIRMA NOP58 INA SEC23IP | 1.26e-04 | 490 | 224 | 16 | int:DLST |
| Interaction | ALB interactions | CYLD USP7 DMD STX17 GCN1 DYNC1H1 VCP RANBP2 RET CPS1 VIRMA CCNA2 CRYAA AP4E1 | 1.30e-04 | 391 | 224 | 14 | int:ALB |
| Interaction | OPHN1 interactions | 1.33e-04 | 24 | 224 | 4 | int:OPHN1 | |
| Interaction | PSMC2 interactions | CYLD C9orf78 PSMD1 PSMD3 PSMD7 PSME1 SUCLA2 HERC2 VCP VIRMA TXNIP SYNE3 INA SLC4A1AP | 1.37e-04 | 393 | 224 | 14 | int:PSMC2 |
| Interaction | PSMA3 interactions | CYLD LRRK2 PSMD1 PSMD3 PSMD7 PSME1 PGK1 SERPINB3 ASPM USP7 UTRN VCP HYOU1 VIRMA RTP5 | 1.38e-04 | 443 | 224 | 15 | int:PSMA3 |
| Interaction | CEBPB interactions | GIPC1 DNAJB11 GIPC2 RPS6KA5 MRPL12 SEPTIN9 NACA PEX1 NASP PSMD1 PSMD3 PSME1 PGK1 SERPINB3 AHNAK ASPM USP7 ZNF638 DYNC1H1 ARMC6 RANBP2 HYOU1 NPEPPS POLR2D BAZ1B POU2F1 RFC4 GLMN NOP58 KMT2D SEC23IP PRPS1 | 1.41e-04 | 1443 | 224 | 32 | int:CEBPB |
| Interaction | PSMB2 interactions | 1.41e-04 | 213 | 224 | 10 | int:PSMB2 | |
| Interaction | HSP90B2P interactions | 1.56e-04 | 25 | 224 | 4 | int:HSP90B2P | |
| Interaction | PMS1 interactions | 1.73e-04 | 105 | 224 | 7 | int:PMS1 | |
| Interaction | MYCBP2 interactions | PDE1B CLASP2 STK3 NGRN SYNE2 HERC2 DYNC1H1 VCP UBR4 VIRMA TXNIP CTNNA3 SSH2 | 1.81e-04 | 355 | 224 | 13 | int:MYCBP2 |
| Interaction | BIRC3 interactions | DENND4A NACA CKAP5 NASP PSMD1 PSMD3 PSMD7 SUCLA2 ME2 PGK1 SERPINB3 USP7 SAMM50 UTP3 GCN1 DYNC1H1 RANBP2 HYOU1 NPEPPS SYNE1 UBR4 POLRMT BAZ1B CPOX RFC4 GLMN NOP58 SEC23IP HDLBP PRPS1 | 1.82e-04 | 1334 | 224 | 30 | int:BIRC3 |
| Interaction | TRRAP interactions | VPS13C NACA PEX1 NASP PSMD3 SERPINB3 USP7 ZNF638 CHD6 DMD DYNC1H1 ABCC1 SYNE1 BAZ1B RFC4 VIRMA THAP11 IVNS1ABP CRYAA INA PCDH9 | 2.07e-04 | 790 | 224 | 21 | int:TRRAP |
| Interaction | RPAP3 interactions | CYLD LRRK2 RGPD1 SAMM50 POLR2D STIL CCNA2 NOP58 SEC23IP PRPS1 | 2.21e-04 | 225 | 224 | 10 | int:RPAP3 |
| Interaction | PRC1 interactions | BDP1 MRPL12 NACA TMOD2 PSMD1 PSMD3 PSMD7 AHNAK ZNF638 UTP3 GCN1 DYNC1H1 VCP RANBP2 SYNE1 POLR2D BAZ1B CPS1 VIRMA ESF1 CCNA2 CCNE1 NOP58 CELSR3 | 2.23e-04 | 973 | 224 | 24 | int:PRC1 |
| Interaction | GFRA1 interactions | 2.29e-04 | 50 | 224 | 5 | int:GFRA1 | |
| Interaction | KBTBD4 interactions | CD2AP CKAP5 PSMD3 AHNAK USP7 VCP RANBP2 UBR4 LRRC40 SAP30BP TXNDC9 HDLBP | 2.30e-04 | 316 | 224 | 12 | int:KBTBD4 |
| Interaction | MTM1 interactions | 2.33e-04 | 78 | 224 | 6 | int:MTM1 | |
| Interaction | IPO5 interactions | CYLD DNAJB11 C9orf78 PSMD3 PSMD7 PSME1 DYNC1H1 VCP RANBP2 POU2F1 VIRMA PREP SEC23IP LSM14B | 2.34e-04 | 414 | 224 | 14 | int:IPO5 |
| Interaction | RPS6KL1 interactions | 2.51e-04 | 51 | 224 | 5 | int:RPS6KL1 | |
| Interaction | MARK2 interactions | 2.60e-04 | 274 | 224 | 11 | int:MARK2 | |
| Interaction | HECTD1 interactions | NACA CKAP5 PSMD3 CDC40 ASPM UTP3 HERC2 GCN1 UTRN AP3D1 VCP BTF3L4 POLE POLRMT BAZ1B RFC4 VIRMA ESF1 THAP11 NOP58 ANKRD11 EXOC1 SSH2 EIF4G3 | 2.63e-04 | 984 | 224 | 24 | int:HECTD1 |
| Interaction | VCP interactions | CYLD DNAJB11 SEPTIN9 NACA PEX1 NASP PSMD1 PSMD3 PSMD7 PSME1 PLD3 SUCLG2 PGK1 RYR3 STK3 PTPN9 USP7 AP3D1 DYNC1H1 VCP ABCC1 RANBP2 HYOU1 NPEPPS UBR4 RDX CAV1 VIRMA SLC5A5 TRIM13 HDLBP | 2.86e-04 | 1435 | 224 | 31 | int:VCP |
| Interaction | MAP4 interactions | CYLD C9orf78 LRRK2 PSMD1 PSMD3 FYCO1 HERC2 HYOU1 VIRMA NOP58 SLC4A1AP SEC23IP | 2.89e-04 | 324 | 224 | 12 | int:MAP4 |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.85e-06 | 4 | 141 | 3 | 1252 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.25e-04 | 13 | 141 | 3 | 1186 | |
| GeneFamily | Cadherin related | 2.91e-04 | 17 | 141 | 3 | 24 | |
| GeneFamily | Proteasome | 3.45e-04 | 43 | 141 | 4 | 690 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.48e-04 | 18 | 141 | 3 | 91 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.17e-03 | 206 | 141 | 7 | 682 | |
| GeneFamily | Cyclins | 1.32e-03 | 28 | 141 | 3 | 473 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.61e-03 | 10 | 141 | 2 | 1178 | |
| GeneFamily | Non-clustered protocadherins | 3.79e-03 | 12 | 141 | 2 | 21 | |
| GeneFamily | Defensins, alpha | 3.79e-03 | 12 | 141 | 2 | 502 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SEPTIN9 CD2AP CKAP5 CLASP2 ME2 STK3 PTPN9 SYNE2 USP7 ZNF638 MICAL3 DMD ABCC1 DPYD STRN3 RANBP2 NPEPPS RHOBTB3 DOCK9 BAZ1B RDX CHD9 STIL EIF4G3 PHLPP2 | 7.49e-08 | 856 | 221 | 25 | M4500 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | DNAJB11 C9orf78 NACA RGPD1 PSMD1 PSMD3 PSMD7 NGRN PPP1R37 MIEF1 UTP3 TSR3 VCP RGPD2 RANBP2 BTF3L4 NPEPPS UBR4 BAZ1B MORC2 THAP11 SLC4A1AP PREP PCIF1 TXNDC9 LSM14B HDLBP PRPS1 | 5.68e-07 | 1158 | 221 | 28 | MM1338 |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | PRPS2 CKAP5 SUCLA2 PGK1 AK4 VCP RDX RFC4 CCNE1 SEC23IP DIXDC1 | 1.09e-06 | 199 | 221 | 11 | M8299 |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | BDP1 SEPTIN9 PEX1 DGKH ABCC1 STRN3 RANBP2 MORC2 IVNS1ABP ELMO2 EIF4G3 | 1.09e-06 | 199 | 221 | 11 | M6932 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | GPRASP1 MAP2 VPS13C TMOD2 PSMD1 CLASP2 PGK1 NGRN SYNE2 NMRK1 UTRN FAM135A DYNC1H1 RANBP2 BTF3L4 CHD9 DGKD RGS16 INA ELMO2 RALGPS1 EIF4G3 AFF4 PRPS1 | 1.71e-06 | 946 | 221 | 24 | M39169 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | DNAJB11 C9orf78 NACA PSMD1 PSMD3 PSMD7 NGRN PPP1R37 MIEF1 UTP3 TSR3 VCP RANBP2 BTF3L4 NPEPPS UBR4 BAZ1B MORC2 THAP11 SLC4A1AP PREP PCIF1 TXNDC9 LSM14B HDLBP PRPS1 | 3.61e-06 | 1129 | 221 | 26 | M42508 |
| Coexpression | GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN | 4.60e-06 | 147 | 221 | 9 | M422 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | CYLD ZBTB6 RPS6KA5 KIF1B PEX1 NASP ACY1 DEFA1 STK3 GORAB USP7 NMRK1 C19orf44 CHD6 UTRN RHOBTB3 RET RGS16 ESF1 IVNS1ABP TXNIP SYNE3 ZMYM5 | 5.34e-06 | 942 | 221 | 23 | M8144 |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP | EPHB3 NBEAL2 AHNAK MICAL3 SAMM50 FMO3 RDX RGS16 EHHADH DIXDC1 | 7.23e-06 | 197 | 221 | 10 | M8414 |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP | 8.26e-06 | 200 | 221 | 10 | M315 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP | 8.26e-06 | 200 | 221 | 10 | M8305 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CYLD BDP1 DENND4A RPS6KA5 C9orf78 VPS13C SEPTIN9 PSME1 FAM13B PGK1 NBEAL2 AHNAK ZNF638 NMRK1 UTRN DYNC1H1 RANBP2 SYNE1 DOCK9 UBR4 BAZ1B RGS16 IVNS1ABP TXNIP KMT2D ELMO2 ANKRD11 SSH2 AP4B1 ZMYM5 | 9.13e-06 | 1492 | 221 | 30 | M40023 |
| Coexpression | BENPORATH_CYCLING_GENES | CKAP5 NASP NUF2 SUCLG2 PTPN9 SERPINB3 AP3D1 CDCA7L RHOBTB3 STIL RFC4 CCNA2 IVNS1ABP CCNE1 SLC4A1AP SAP30BP TXNDC9 AP4B1 | 1.08e-05 | 648 | 221 | 18 | M8156 |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_DN | BACH2 PSME1 SUCLG2 USP7 CRYZL1 RUBCNL CPOX NXN SYNE3 SEC23IP TRIM13 | 1.81e-05 | 267 | 221 | 11 | M6663 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CKAP5 NASP NUF2 ASPM WNK2 POLE LRRC40 STIL RFC4 RGS16 CCNA2 CCNE1 PCDHB18P NOP58 INA CELSR3 RALGPS1 PROX1 | 2.06e-05 | 680 | 221 | 18 | MM456 |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 4.26e-05 | 242 | 221 | 10 | M2128 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MAP2 TMOD2 NOVA2 GRIA1 POU2F1 VSTM2B INA CELSR3 ZFHX4 PLXNC1 RALGPS1 TRIM13 PCDH9 PROX1 | 4.48e-05 | 465 | 221 | 14 | M39066 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 DNAJB11 VPS13C NUF2 FAM13B SYNE2 ASPM ZNF638 GAREM1 RUBCNL BAZ1B RDX LRRC40 ESF1 SLC4A1AP PLXNC1 EXOC1 | 4.57e-05 | 656 | 221 | 17 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SEPTIN9 CD2AP CKAP5 CLASP2 STK3 ZNF638 MICAL3 DPYD STRN3 NPEPPS CHD9 STIL EIF4G3 PHLPP2 | 4.58e-05 | 466 | 221 | 14 | M13522 |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN | 4.95e-05 | 198 | 221 | 9 | M3325 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_DN | 4.95e-05 | 198 | 221 | 9 | M5454 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 5.15e-05 | 199 | 221 | 9 | M9236 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | 5.35e-05 | 200 | 221 | 9 | M9467 | |
| Coexpression | GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN | 5.35e-05 | 200 | 221 | 9 | M7083 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 5.35e-05 | 200 | 221 | 9 | M10091 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_UP | 5.35e-05 | 200 | 221 | 9 | M4893 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN | 5.35e-05 | 200 | 221 | 9 | M3414 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 5.35e-05 | 200 | 221 | 9 | M7150 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | DENND4A KIF1B PEX1 PSMD1 CLASP2 SUCLA2 PGK1 CDC40 SAMM50 HERC2 DMD DYNC1H1 VCP RANBP2 HYOU1 NPEPPS GRIA1 CNNM1 INA ELMO2 PREP SEC23IP TXNDC9 EXOC1 PRPS1 | 5.74e-05 | 1248 | 221 | 25 | M17728 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 6.73e-05 | 206 | 221 | 9 | M2817 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | CYLD GPRASP1 DENND4A RPS6KA5 BACH2 KIF1B VCP DIP2B RANBP2 NDUFAF5 POLR2D VIRMA IVNS1ABP NOP58 PCIF1 EIF4G3 AFF4 | 7.10e-05 | 680 | 221 | 17 | M41089 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 7.24e-05 | 208 | 221 | 9 | MM581 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 9.00e-05 | 86 | 221 | 6 | M39247 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | VPS13C NASP DGKH APOM CDC40 TECPR2 SYNE2 NPEPPS SYNE1 DOCK9 RDX PCIF1 THNSL2 PCDH9 ZMYM5 | 1.03e-04 | 567 | 221 | 15 | M16909 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.07e-04 | 171 | 221 | 8 | M39234 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | CYLD ZBTB6 RPS6KA5 KIF1B PEX1 NASP STK3 GORAB NMRK1 CHD6 UTRN RHOBTB3 RET RGS16 IVNS1ABP TXNIP SYNE3 ZMYM5 | 1.16e-04 | 778 | 221 | 18 | M17915 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MAP2 CKAP5 NASP NUF2 ASPM AK4 CDCA7L POLE STIL RFC4 CCNA2 CCNE1 NOP58 GJC3 CDH6 | 1.27e-04 | 578 | 221 | 15 | M2368 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.27e-04 | 276 | 221 | 10 | M3063 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.35e-04 | 177 | 221 | 8 | M39245 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.52e-04 | 180 | 221 | 8 | M8239 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_UP | 1.52e-04 | 180 | 221 | 8 | M19929 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | GIPC1 RPS6KA5 KIF1B DGKH ME2 DMD ABCC1 STRN3 FRAS1 DOCK9 POU2F1 NXN ZFHX4 DIXDC1 THNSL2 | 1.55e-04 | 589 | 221 | 15 | M45662 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | KIF1B CLASP2 PSME1 RYR3 SYNE2 NMRK1 HERC2 NPEPPS DOCK9 TXNIP DIXDC1 | 1.59e-04 | 340 | 221 | 11 | M2012 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MAP2 CKAP5 NASP NUF2 ASPM AK4 CDCA7L POLE STIL RFC4 CCNA2 CCNE1 NOP58 GJC3 CDH6 | 1.80e-04 | 597 | 221 | 15 | MM1309 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CYLD BDP1 GPRASP1 PDE1B MAP2 BACH2 LRRK2 PEX1 TMOD2 GIGYF1 MICAL3 DIP2B GRIA1 POU2F1 INA CELSR3 ZFHX4 PLXNC1 RALGPS1 SBF2 SSH2 PCDH9 | 1.80e-04 | 1106 | 221 | 22 | M39071 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.97e-04 | 187 | 221 | 8 | M2984 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | CYLD MYLK PLD3 SERPINB3 DIP2B DPYD FRAS1 RHOBTB3 TXNIP SYNE3 | 2.11e-04 | 294 | 221 | 10 | M1804 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 2.13e-04 | 240 | 221 | 9 | M39236 | |
| Coexpression | RUIZ_TNC_TARGETS_DN | 2.18e-04 | 143 | 221 | 7 | M19048 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN | 2.20e-04 | 190 | 221 | 8 | M7317 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_UP | KIF1B ASPM DYNC1H1 ABCC1 RHOBTB3 CCNE1 PLXNC1 ELMO2 RALGPS1 TXNDC9 | 2.35e-04 | 298 | 221 | 10 | M1918 |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | GIPC1 CYLD MYLK CLASP2 TECPR2 GAREM1 DIP2B DOCK9 POMGNT1 VSTM2B CPOX CTNNA3 IPO13 TXNDC9 DIXDC1 SSH2 GALNT6 | 2.42e-04 | 754 | 221 | 17 | M39037 |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | MYLK PGK1 PTPN9 DPYD DGKD CAV1 RFC4 RGS16 CCNA2 EIF4G3 PCOLCE | 2.53e-04 | 359 | 221 | 11 | M15193 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 2.71e-04 | 196 | 221 | 8 | M41105 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 2.71e-04 | 196 | 221 | 8 | M9243 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP | 2.81e-04 | 197 | 221 | 8 | M6125 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 2.81e-04 | 197 | 221 | 8 | M5378 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_DN | 2.81e-04 | 197 | 221 | 8 | M5161 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAC_UP | 2.81e-04 | 197 | 221 | 8 | M5401 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | EPHB3 PRPS2 CD2AP NACA NASP NUF2 UTP3 DMD FRAS1 POLE RHOBTB3 RFC4 CCNA2 NOP58 | 2.83e-04 | 555 | 221 | 14 | M2343 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | PRPS2 CKAP5 NUF2 SYNE2 ASPM CDCA7L POLE BAZ1B RDX POU2F1 LRRC40 STIL RFC4 CCNA2 CCNE1 PRPS1 | 2.89e-04 | 694 | 221 | 16 | M45767 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 2.90e-04 | 38 | 221 | 4 | M39244 | |
| Coexpression | GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN | 2.90e-04 | 198 | 221 | 8 | M7707 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_DN | 2.90e-04 | 198 | 221 | 8 | M5411 | |
| Coexpression | GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP | 2.90e-04 | 198 | 221 | 8 | M4432 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_UP | 3.00e-04 | 199 | 221 | 8 | M4650 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN | 3.00e-04 | 199 | 221 | 8 | M4523 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP | 3.00e-04 | 199 | 221 | 8 | M8429 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 3.00e-04 | 199 | 221 | 8 | M6646 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN | 3.00e-04 | 199 | 221 | 8 | M5382 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 3.00e-04 | 199 | 221 | 8 | M6638 | |
| Coexpression | GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 3.00e-04 | 199 | 221 | 8 | M7865 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 3.00e-04 | 199 | 221 | 8 | M9124 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 3.00e-04 | 199 | 221 | 8 | M3070 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 3.11e-04 | 200 | 221 | 8 | M9463 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 3.11e-04 | 200 | 221 | 8 | M9458 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN | 3.11e-04 | 200 | 221 | 8 | M4832 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 3.11e-04 | 200 | 221 | 8 | M8312 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 3.11e-04 | 200 | 221 | 8 | M3580 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 3.11e-04 | 200 | 221 | 8 | M7505 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 3.11e-04 | 200 | 221 | 8 | M6016 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 3.11e-04 | 200 | 221 | 8 | M5063 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_UP | 3.11e-04 | 200 | 221 | 8 | M6426 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN | 3.11e-04 | 200 | 221 | 8 | M6601 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP | 3.11e-04 | 200 | 221 | 8 | M6584 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.11e-04 | 200 | 221 | 8 | M9122 | |
| Coexpression | VANTVEER_BREAST_CANCER_METASTASIS_DN | 3.30e-04 | 109 | 221 | 6 | M9826 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.37e-04 | 71 | 221 | 5 | M9544 | |
| Coexpression | GSE11818_WT_VS_DICER_KO_TREG_DN | 3.43e-04 | 154 | 221 | 7 | M411 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | CKAP5 NUF2 SYNE2 ASPM MMP16 CDCA7L FRAS1 EVC2 CCNA2 IPO13 CDH6 PCDH9 | 3.63e-04 | 437 | 221 | 12 | M1610 |
| Coexpression | GARY_CD5_TARGETS_DN | DNAJB11 NASP PSMD1 AK4 SAMM50 UTP3 TXNIP GLMN NOP58 SEC23IP TXNDC9 AP4B1 | 3.86e-04 | 440 | 221 | 12 | M13893 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | DNAJB11 RPS6KA5 NASP NUF2 APOM ASPM UTP3 BTF3L4 LRRC40 STIL RFC4 CCNA2 NOP58 CTNNA3 RPUSD2 AP4B1 | 3.94e-04 | 714 | 221 | 16 | M1744 |
| Coexpression | LU_AGING_BRAIN_UP | 4.17e-04 | 263 | 221 | 9 | M5547 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | PRPS2 RPS6KA5 NASP CLASP2 NUF2 HPSE SYNE2 ASPM CRYZL1 VCP BAZ1B STIL CPS1 RFC4 CCNA2 CCNE1 EHHADH NR2C2AP TRIM13 PHLPP2 | 4.44e-04 | 1023 | 221 | 20 | M17122 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.69e-04 | 43 | 221 | 4 | MM3857 | |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 5.13e-04 | 44 | 221 | 4 | M2536 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | CKAP5 NUF2 SYNE2 ASPM MMP16 CDCA7L FRAS1 EVC2 CCNA2 IPO13 CDH6 PCDH9 | 5.19e-04 | 455 | 221 | 12 | MM1189 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | RPS6KA5 RGPD1 NASP FYCO1 NUF2 RNASEK ME2 FAM13B CDC40 NMRK1 ARMC6 RGPD2 RANBP2 RDX MORC2 NXN TXNIP SYNE3 SLC4A1AP PLXNC1 EHHADH AP4B1 PRPS1 | 5.24e-04 | 1277 | 221 | 23 | MM1032 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | CYLD GPRASP1 MYLK RPS6KA5 VPS13C FYCO1 HEBP1 SYNE2 DMD CHD9 TXNIP LRIG3 THNSL2 TRIM13 ZMYM5 AFF4 PROX1 | 5.26e-04 | 807 | 221 | 17 | M16651 |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_UP | 6.39e-04 | 223 | 221 | 8 | M11383 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 VPS13C CKAP5 NASP ME2 ASPM USP7 ZNF638 MICAL3 UTP3 ABCC1 RANBP2 POLE RHOBTB3 POU2F1 STIL ESF1 PLXNC1 ANKRD11 RPUSD2 | 6.62e-07 | 532 | 218 | 20 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | FILIP1 MYLK RPS6KA5 CD2AP KIF1B TMOD2 CLASP2 RYR3 ASPM ZNF638 MMP16 FAM135A B3GNT9 SYNE1 RHOBTB3 BAZ1B VSTM2B CAV1 ZFHX4 SNTG2 DIXDC1 PCDH9 HDLBP | 4.98e-06 | 772 | 218 | 23 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 PDE1B BACH2 CKAP5 NASP ME2 SYNE2 ASPM USP7 AK4 UTP3 DMD ZNF606 BTF3L4 POLE RHOBTB3 BAZ1B RDX POU2F1 CHD9 STIL RFC4 ESF1 CCNA2 CCNE1 NOP58 SLC4A1AP RPUSD2 DIXDC1 CDH6 ZMYM5 | 5.30e-06 | 1257 | 218 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | BDP1 MAP2 CKAP5 NASP SYNE2 ASPM AK4 DMD CDCA7L RANBP2 POU2F1 RGS16 INA PLXNC1 RALGPS1 RPUSD2 PCDH9 | 1.45e-05 | 493 | 218 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 PDE1B MAP2 BACH2 CKAP5 NASP ME2 SYNE2 ASPM USP7 AK4 UTP3 DMD ZNF606 NOVA2 BTF3L4 POLE RHOBTB3 BAZ1B RDX POU2F1 CHD9 STIL RFC4 ESF1 CCNA2 CCNE1 NOP58 SLC4A1AP RPUSD2 DIXDC1 CDH6 ZMYM5 | 1.55e-05 | 1459 | 218 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | MYLK FREM1 HEBP1 NMRK1 MMP16 FAM135A RHOBTB3 GRIA1 DGKD CCNE1 PLXNC1 SEC23IP DIXDC1 PCDH9 HDLBP | 2.51e-05 | 412 | 218 | 15 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | BDP1 MAP2 VPS13C CKAP5 NASP ME2 SYNE2 ASPM AK4 CHD6 UTP3 DMD CDCA7L WNK2 DPYD RANBP2 POU2F1 RGS16 INA SLC4A1AP PLXNC1 RALGPS1 ANKRD11 RPUSD2 PCDH9 | 2.84e-05 | 983 | 218 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | KIF1B NASP SYNE2 ASPM USP7 ZNF606 MMP16 UTRN CHD9 ANKRD11 CDH6 PCDH9 | 3.13e-05 | 277 | 218 | 12 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | DENND4A MAP2 KIF1B TMOD2 CLASP2 RET RFC4 INA CELSR3 CDH6 PCDH9 PROX1 | 3.24e-05 | 278 | 218 | 12 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | MAP2 BACH2 KIF1B TMOD2 CLASP2 ASPM USP7 HERC2 MMP16 VCP RHOBTB3 BAZ1B DIXDC1 | 3.94e-05 | 330 | 218 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | KIF1B NASP RNASEK SYNE2 ASPM USP7 MMP16 UTRN GAREM1 CHD9 ANKRD11 PCDH9 | 3.99e-05 | 284 | 218 | 12 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | KIF1B NASP SYNE2 ASPM USP7 MMP16 UTRN HYOU1 CHD9 ANKRD11 PCDH9 | 8.00e-05 | 259 | 218 | 11 | gudmap_developingGonad_e12.5_epididymis_k3_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | EPHB3 MAP2 BACH2 CKAP5 NASP TMOD2 FYCO1 FREM1 SYNE2 ASPM ZNF638 AK4 ZNF606 FAM135A POLE RHOBTB3 CHD9 LRRC40 STIL ESF1 CCNA2 AP4E1 GLMN NOP58 EHHADH DIXDC1 CDH6 ZMYM5 | 8.86e-05 | 1252 | 218 | 28 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000 | MYLK TMOD2 CLASP2 FREM1 HEBP1 AHNAK NMRK1 ZNF606 MMP16 FAM135A RHOBTB3 BAZ1B GRIA1 DGKD NRIP3 CCNE1 PLXNC1 SEC23IP DIXDC1 PCDH9 HDLBP | 9.63e-05 | 809 | 218 | 21 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 CKAP5 NASP ME2 ASPM ZNF638 UTP3 RANBP2 POLE BAZ1B POU2F1 LRRC40 ESF1 NOP58 ANKRD11 | 1.08e-04 | 469 | 218 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | FILIP1 MYLK BACH2 KIF1B NASP CLASP2 RYR3 USP7 HERC2 MMP16 GCN1 VCP RHOBTB3 BAZ1B GRIA1 DGKD RET INA CELSR3 ZFHX4 HDLBP | 1.12e-04 | 818 | 218 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | VPS13C NASP ME2 SYNE2 ASPM UTP3 DMD DPYD RANBP2 SLC4A1AP PLXNC1 PCDH9 | 1.57e-04 | 328 | 218 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MYLK KIF1B NASP PSMD7 RNASEK ZNF229 SYNE2 ASPM USP7 MMP16 UTRN GAREM1 DPYD B3GNT9 RHOBTB3 CHD9 VSTM2B ESF1 ANKRD11 PCDH9 | 1.97e-04 | 790 | 218 | 20 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 2.50e-04 | 55 | 218 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.60e-04 | 203 | 218 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | ATP7B NASP NUF2 HEBP1 ASPM GAREM1 POLE STIL CPOX RFC4 CCNA2 CCNE1 NOP58 | 2.74e-04 | 401 | 218 | 13 | GSM791108_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 2.77e-04 | 162 | 218 | 8 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MAP2 BACH2 KIF1B TMOD2 CLASP2 RYR3 ASPM USP7 HERC2 MMP16 FAM135A VCP RHOBTB3 BAZ1B GRIA1 RET INA ZFHX4 DIXDC1 CDH6 | 3.10e-04 | 818 | 218 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | CKAP5 NASP NUF2 NBEAL2 AHNAK ASPM CDCA7L POLE STIL CPOX RFC4 CCNA2 CCNE1 | 3.39e-04 | 410 | 218 | 13 | GSM538387_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | EPHB3 DENND4A MAP2 KIF1B NASP PLD3 NGRN SYNE2 ASPM CHD6 UTP3 DMD WNK2 B3GNT9 NPEPPS RGS16 PLXNC1 RALGPS1 PCDH9 PHLPP2 PROX1 | 3.68e-04 | 893 | 218 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DENND4A VPS13C CKAP5 NASP ME2 SYNE2 ASPM CHD6 UTP3 DMD DPYD RANBP2 SLC4A1AP PLXNC1 RPUSD2 PCDH9 PHLPP2 | 4.44e-04 | 654 | 218 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-07 | 176 | 223 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-07 | 178 | 223 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-07 | 184 | 223 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DENND4A VPS13C DGKH SYNE2 UTRN DYNC1H1 RANBP2 NPEPPS ANKRD11 | 4.75e-07 | 188 | 223 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-07 | 190 | 223 | 9 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-07 | 190 | 223 | 9 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-07 | 190 | 223 | 9 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.91e-07 | 193 | 223 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-07 | 199 | 223 | 9 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-07 | 199 | 223 | 9 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 7.96e-07 | 200 | 223 | 9 | b0d708715f09ec1f67fdef3b100a91c8ff2747a7 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.96e-07 | 200 | 223 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-06 | 174 | 223 | 8 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-06 | 180 | 223 | 8 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-06 | 187 | 223 | 8 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.79e-06 | 187 | 223 | 8 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-06 | 191 | 223 | 8 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 191 | 223 | 8 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.81e-06 | 192 | 223 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-06 | 193 | 223 | 8 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.04e-06 | 193 | 223 | 8 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-06 | 193 | 223 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-06 | 194 | 223 | 8 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 6.27e-06 | 194 | 223 | 8 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.01e-06 | 197 | 223 | 8 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.01e-06 | 197 | 223 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.01e-06 | 197 | 223 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 7.01e-06 | 197 | 223 | 8 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.28e-06 | 198 | 223 | 8 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.28e-06 | 198 | 223 | 8 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 7.28e-06 | 198 | 223 | 8 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 7.55e-06 | 199 | 223 | 8 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 199 | 223 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 7.55e-06 | 199 | 223 | 8 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.55e-06 | 199 | 223 | 8 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 7.55e-06 | 199 | 223 | 8 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-06 | 200 | 223 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.83e-06 | 200 | 223 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 7.83e-06 | 200 | 223 | 8 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-06 | 200 | 223 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.83e-06 | 200 | 223 | 8 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-05 | 170 | 223 | 7 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-05 | 170 | 223 | 7 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.42e-05 | 170 | 223 | 7 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-05 | 170 | 223 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 171 | 223 | 7 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 171 | 223 | 7 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 2.61e-05 | 172 | 223 | 7 | c3822ff7329c3ac38c68c5c38cd67c390682e2a6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 173 | 223 | 7 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 173 | 223 | 7 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 173 | 223 | 7 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.81e-05 | 174 | 223 | 7 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-05 | 174 | 223 | 7 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 175 | 223 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.03e-05 | 176 | 223 | 7 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.14e-05 | 177 | 223 | 7 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 178 | 223 | 7 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 3.37e-05 | 179 | 223 | 7 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-05 | 180 | 223 | 7 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-05 | 180 | 223 | 7 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-05 | 180 | 223 | 7 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 180 | 223 | 7 | 350ba05cec45a788ab33530cc1346daddb00f884 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-05 | 180 | 223 | 7 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 223 | 7 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 182 | 223 | 7 | 0beffe6b9b36cfd196ec98a18f6ded080c162f90 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 182 | 223 | 7 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.75e-05 | 182 | 223 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 182 | 223 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 183 | 223 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-05 | 183 | 223 | 7 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.88e-05 | 183 | 223 | 7 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-05 | 183 | 223 | 7 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 184 | 223 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 184 | 223 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 4.02e-05 | 184 | 223 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 184 | 223 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 185 | 223 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-05 | 185 | 223 | 7 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.30e-05 | 186 | 223 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 4.45e-05 | 187 | 223 | 7 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-05 | 187 | 223 | 7 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 187 | 223 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 187 | 223 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-05 | 187 | 223 | 7 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.45e-05 | 187 | 223 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 187 | 223 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 187 | 223 | 7 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 4.45e-05 | 187 | 223 | 7 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 187 | 223 | 7 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-05 | 188 | 223 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-05 | 188 | 223 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-05 | 188 | 223 | 7 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-05 | 188 | 223 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.61e-05 | 188 | 223 | 7 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-05 | 188 | 223 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.61e-05 | 188 | 223 | 7 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.61e-05 | 188 | 223 | 7 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 4.76e-05 | 189 | 223 | 7 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.76e-05 | 189 | 223 | 7 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.76e-05 | 189 | 223 | 7 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.76e-06 | 49 | 145 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | adefovir | 3.04e-06 | 64 | 223 | 7 | CID000060172 | |
| Drug | HPMPApp | 8.30e-06 | 14 | 223 | 4 | CID000506018 | |
| Drug | allose | 1.81e-05 | 6 | 223 | 3 | ctd:C002055 | |
| Drug | methyl iodoacetate | 1.81e-05 | 6 | 223 | 3 | CID006429536 | |
| Drug | APP-MP | 1.81e-05 | 6 | 223 | 3 | CID003081102 | |
| Drug | pyrimidine-5-nucleotide | 1.81e-05 | 6 | 223 | 3 | CID000440040 | |
| Drug | Thimerosal | BDP1 SEPTIN9 NASP TMOD2 CLASP2 GIGYF1 PGK1 RYR3 HEBP1 SYNE2 ASPM AK4 MMP16 FAM135A VCP GAREM1 EVC2 RHOBTB3 POLRMT CHD9 CPS1 ESF1 TXNIP PLXNC1 TXNDC9 TRIM13 LSM14B AFF4 | 1.85e-05 | 1199 | 223 | 28 | ctd:D013849 |
| Drug | eg D | 1.90e-05 | 34 | 223 | 5 | CID000029544 | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | EPHB3 DENND4A STK3 ASPM AP3D1 RHOBTB3 POLR2D ANKRD11 EIF4G3 DHX34 | 1.99e-05 | 191 | 223 | 10 | 2857_DN |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; PC3; HT_HG-U133A | SEPTIN9 ZNF606 UTRN ARMC6 STRN3 CPS1 AP4E1 CNNM1 LSM14B PCOLCE | 2.38e-05 | 195 | 223 | 10 | 5834_UP |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A | NDUFAF5 UBR4 BAZ1B RET NRIP3 PLXNC1 RALGPS1 DHX34 PHLPP2 PROX1 | 2.71e-05 | 198 | 223 | 10 | 3824_UP |
| Drug | Chrysin [480-40-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A | GPRASP1 MAP2 UTRN NDUFAF5 CPS1 NRIP3 INA PLXNC1 RALGPS1 ZNF44 | 2.83e-05 | 199 | 223 | 10 | 5505_UP |
| Drug | (+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 2.83e-05 | 199 | 223 | 10 | 954_DN | |
| Drug | benzbromarone | 2.91e-05 | 37 | 223 | 5 | CID000002333 | |
| Drug | fructose 3-phosphate | 3.84e-05 | 20 | 223 | 4 | CID000130872 | |
| Disease | Charcot-Marie-Tooth disease | 1.37e-05 | 42 | 216 | 5 | cv:C0007959 | |
| Disease | Malignant neoplasm of breast | ATP7B ACY1 HPSE CDH20 SYNE2 HERC2 DMD ABCC1 DPYD SYNE1 UBR4 POU2F1 CAV1 RFC4 SLC5A5 CRYAA CCNE1 KMT2D INA UNC45B HDLBP PRPS1 | 1.47e-05 | 1074 | 216 | 22 | C0006142 |
| Disease | Unilateral agenesis of kidney | 2.11e-05 | 8 | 216 | 3 | C0266294 | |
| Disease | lip morphology measurement | 8.11e-05 | 189 | 216 | 8 | EFO_0007845 | |
| Disease | urolithiasis | 9.99e-05 | 63 | 216 | 5 | MONDO_0024647 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.34e-04 | 67 | 216 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.54e-04 | 69 | 216 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | polycystic ovary syndrome, fasting blood glucose measurement | 1.59e-04 | 3 | 216 | 2 | EFO_0000660, EFO_0004465 | |
| Disease | alkaline phosphatase measurement | GIPC2 RPS6KA5 NGRN AHNAK PPP1R37 MIEF1 MICAL3 UTRN ARMC6 BAZ1B CPS1 NOP58 SLC4A1AP PCIF1 THNSL2 EIF4G3 LSM14B PHLPP2 HDLBP | 1.85e-04 | 1015 | 216 | 19 | EFO_0004533 |
| Disease | C-reactive protein measurement | DCHS2 GIPC2 VPS13C DGKH AHNAK PCDH15 PPP1R37 AK4 MICAL3 GCN1 DPYD BAZ1B GRIA1 GLMN NOP58 SLC4A1AP PCIF1 THNSL2 EIF4G3 AFF4 HDLBP | 2.27e-04 | 1206 | 216 | 21 | EFO_0004458 |
| Disease | Nuclear non-senile cataract | 2.91e-04 | 18 | 216 | 3 | C1112705 | |
| Disease | Nuclear cataract | 2.91e-04 | 18 | 216 | 3 | C0392557 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 3.17e-04 | 4 | 216 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | gamma-glutamylcitrulline measurement | 3.17e-04 | 4 | 216 | 2 | EFO_0800690 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.17e-04 | 4 | 216 | 2 | cv:CN293514 | |
| Disease | Severe intellectual disability and progressive spastic paraplegia | 3.17e-04 | 4 | 216 | 2 | C4755264 | |
| Disease | Alzheimer disease, polygenic risk score | ATP7B CD2AP LRRK2 GIGYF1 ZNF229 STK3 PPP1R37 NOVA2 FRAS1 GRIA1 RET CTNNA3 EIF4G3 | 4.15e-04 | 586 | 216 | 13 | EFO_0030082, MONDO_0004975 |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.26e-04 | 5 | 216 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.26e-04 | 5 | 216 | 2 | C0410190 | |
| Disease | Congenital absence of kidneys syndrome | 5.26e-04 | 5 | 216 | 2 | C1609433 | |
| Disease | platelet measurement | 5.57e-04 | 315 | 216 | 9 | EFO_0005036 | |
| Disease | Squamous cell carcinoma of the head and neck | 5.74e-04 | 52 | 216 | 4 | C1168401 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 6.15e-04 | 23 | 216 | 3 | C1708353 | |
| Disease | hair colour measurement | GIPC2 RGS21 AHNAK SYNE2 HERC2 STX17 FRAS1 KMT2D EHHADH RALGPS1 SBF2 ANKRD11 THNSL2 | 6.51e-04 | 615 | 216 | 13 | EFO_0007822 |
| Disease | urate measurement, bone density | GIPC1 BACH2 CD2AP CLASP2 FREM1 UTRN FAM135A FRAS1 SYNE1 DGKD PLXNC1 ANKRD11 CDH12 | 6.91e-04 | 619 | 216 | 13 | EFO_0003923, EFO_0004531 |
| Disease | Ischemic stroke, fibrinogen measurement | 7.11e-04 | 55 | 216 | 4 | EFO_0004623, HP_0002140 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 7.17e-04 | 145 | 216 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.85e-04 | 6 | 216 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.85e-04 | 6 | 216 | 2 | C0410189 | |
| Disease | clubfoot (implicated_via_orthology) | 7.85e-04 | 6 | 216 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | post-operative acute kidney injury, response to surgery | 7.85e-04 | 6 | 216 | 2 | EFO_0009951, EFO_0009955 | |
| Disease | Congenital cataract | 7.85e-04 | 6 | 216 | 2 | C0009691 | |
| Disease | fibrinogen measurement, coronary artery disease | 9.81e-04 | 154 | 216 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.09e-03 | 7 | 216 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.09e-03 | 7 | 216 | 2 | C0751337 | |
| Disease | cutaneous melanoma, hair color | 1.12e-03 | 62 | 216 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | fibrinogen measurement | 1.27e-03 | 109 | 216 | 5 | EFO_0004623 | |
| Disease | apolipoprotein B measurement | DCHS2 GIGYF1 ZNF229 SYNE2 PPP1R37 NOVA2 ARMC6 NPEPPS BAZ1B NOP58 SLC4A1AP PCIF1 HDLBP | 1.29e-03 | 663 | 216 | 13 | EFO_0004615 |
| Disease | cardiac arrhythmia | 1.36e-03 | 30 | 216 | 3 | EFO_0004269 | |
| Disease | Disease Exacerbation | 1.40e-03 | 165 | 216 | 6 | C0235874 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0800533 | |
| Disease | Drug habituation | 1.60e-03 | 115 | 216 | 5 | C0013170 | |
| Disease | Drug abuse | 1.60e-03 | 115 | 216 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.60e-03 | 115 | 216 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.60e-03 | 115 | 216 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.60e-03 | 115 | 216 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.60e-03 | 115 | 216 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.60e-03 | 115 | 216 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.60e-03 | 115 | 216 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.60e-03 | 115 | 216 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.67e-03 | 116 | 216 | 5 | C0740858 | |
| Disease | atrial fibrillation | 1.74e-03 | 371 | 216 | 9 | EFO_0000275 | |
| Disease | nephrolithiasis | 1.79e-03 | 33 | 216 | 3 | EFO_0004253 | |
| Disease | cutaneous melanoma | 2.01e-03 | 121 | 216 | 5 | EFO_0000389 | |
| Disease | QT interval | GIPC2 SUCLA2 FAM13B GORAB ABCC1 FRAS1 POLR2D DGKD CAV1 LRIG3 PREP | 2.05e-03 | 534 | 216 | 11 | EFO_0004682 |
| Disease | basophil percentage of leukocytes | 2.17e-03 | 243 | 216 | 7 | EFO_0007992 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.31e-03 | 36 | 216 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.56e-03 | 128 | 216 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.56e-03 | 128 | 216 | 5 | C0007134 | |
| Disease | lymphocyte count | BACH2 KIF1B PSMD3 GIGYF1 PLD3 AHNAK USP7 ZNF638 C19orf44 MICAL3 AP3D1 ABCC1 FRAS1 PCDHGA11 DGKD CAV1 CPS1 NXN GLMN ANKRD11 SSH2 | 2.62e-03 | 1464 | 216 | 21 | EFO_0004587 |
| Disease | 3-methylglutarylcarnitine (2) measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0800074 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 3.01e-03 | 328 | 216 | 8 | EFO_0008377, EFO_0008378 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.35e-03 | 12 | 216 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | tryptophan betaine measurement | 3.35e-03 | 12 | 216 | 2 | EFO_0021017 | |
| Disease | decanoylcarnitine measurement | 3.35e-03 | 12 | 216 | 2 | EFO_0021039 | |
| Disease | reaction time measurement | GIPC2 BACH2 LRRK2 ZNF638 CHD6 DPYD GRIA1 RGS16 CCNE1 KMT2D CTNNA3 EIF4G3 | 3.52e-03 | 658 | 216 | 12 | EFO_0008393 |
| Disease | Autism Spectrum Disorders | 3.56e-03 | 85 | 216 | 4 | C1510586 | |
| Disease | Bladder Neoplasm | 3.76e-03 | 140 | 216 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.88e-03 | 141 | 216 | 5 | C0005684 | |
| Disease | alcohol and nicotine codependence | 3.95e-03 | 13 | 216 | 2 | EFO_0004776 | |
| Disease | glutaroyl carnitine measurement | 3.95e-03 | 13 | 216 | 2 | EFO_0021005 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 4.38e-03 | 45 | 216 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.38e-03 | 45 | 216 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Colorectal Neoplasms | 4.47e-03 | 277 | 216 | 7 | C0009404 | |
| Disease | homocysteine measurement | 4.66e-03 | 46 | 216 | 3 | EFO_0004578 | |
| Disease | osteoarthritis, hip | 4.72e-03 | 92 | 216 | 4 | EFO_1000786 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.76e-03 | 148 | 216 | 5 | C0279702 | |
| Disease | Autosomal recessive primary microcephaly | 5.26e-03 | 15 | 216 | 2 | cv:C3711387 | |
| Disease | Neoplasm Metastasis | 5.42e-03 | 217 | 216 | 6 | C0027627 | |
| Disease | Prostatic Neoplasms | ATP7B USP7 CHD6 VCP PCDH11Y CAV1 SLC5A5 IVNS1ABP KMT2D EHHADH CDH12 | 5.98e-03 | 616 | 216 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ATP7B USP7 CHD6 VCP PCDH11Y CAV1 SLC5A5 IVNS1ABP KMT2D EHHADH CDH12 | 5.98e-03 | 616 | 216 | 11 | C0376358 |
| Disease | Congenital total cataract | 5.98e-03 | 16 | 216 | 2 | C0266539 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 5.98e-03 | 16 | 216 | 2 | C1257877 | |
| Disease | succinylcarnitine measurement | 5.98e-03 | 16 | 216 | 2 | EFO_0020020 | |
| Disease | total blood protein measurement | 6.09e-03 | 449 | 216 | 9 | EFO_0004536 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 6.09e-03 | 157 | 216 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | testosterone measurement | DCHS2 DENND4A SEPTIN9 NUF2 PTPN9 SYNE2 USP7 UTRN DIP2B FMO3 NPEPPS BAZ1B GLMN ZFHX4 SLC4A1AP SBF2 SEC23IP PROX1 | 6.13e-03 | 1275 | 216 | 18 | EFO_0004908 |
| Disease | alpha fetoprotein measurement | 6.33e-03 | 100 | 216 | 4 | EFO_0010583 | |
| Disease | blood urea nitrogen measurement | 6.35e-03 | 452 | 216 | 9 | EFO_0004741 | |
| Disease | Breast Carcinoma | 6.58e-03 | 538 | 216 | 10 | C0678222 | |
| Disease | muscular dystrophy (is_implicated_in) | 6.75e-03 | 17 | 216 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | glutarylcarnitine (C5-DC) measurement | 6.75e-03 | 17 | 216 | 2 | EFO_0800030 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 6.75e-03 | 17 | 216 | 2 | cv:C0270914 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.75e-03 | 17 | 216 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | creatinine measurement | GIPC2 NASP PSMD1 DGKH PTPN9 CDH20 CHD9 CPS1 CCNA2 AP4E1 GLMN CELSR3 PLXNC1 ANKRD11 LSM14B | 6.80e-03 | 995 | 216 | 15 | EFO_0004518 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDSLKETVVPIFEAT | 1146 | Q5RHP9 | |
| SFEAAAIPVAEKEEA | 191 | Q9BYV9 | |
| EEEDVILQPEKNDSF | 761 | A6H8Y1 | |
| EIEAAVKAAREAFPS | 46 | Q9H2A2 | |
| TKEELATFDPVDNIV | 56 | O95445 | |
| EKLDPIAADQQDTVV | 161 | Q9Y6F7 | |
| PKLDVALEAAVEAET | 2211 | Q6UB99 | |
| ATPEEFEAIAELKSD | 116 | Q8N6M5 | |
| AVAEKAERSPVTFFD | 751 | P35670 | |
| PVDDAEVDELVLQTK | 1321 | Q9UIG0 | |
| SQAAAEVDVTVAKPD | 246 | Q16352 | |
| PEEAVKEAVEQFESQ | 51 | Q6NXE6 | |
| TQSEEKADFVIIPAE | 236 | Q155Q3 | |
| RKANVTVFLQDPDEE | 31 | P24864 | |
| VNEEEEFIPQVKDFT | 206 | Q6ZMN8 | |
| VLEDFVENVKSETFP | 456 | Q9Y6B7 | |
| IDASLKAPDVDVNIA | 5051 | Q09666 | |
| TELKADFPDNIVIAS | 626 | Q12882 | |
| ATVEDLPSAFEEKAI | 251 | O14908 | |
| KVNPDEFAVALDETL | 276 | Q8TF65 | |
| LFPSNFVKELEVTDD | 156 | Q9Y5K6 | |
| KNEAEPEFASRLETE | 1116 | P11532 | |
| NHEEAEEKPDLFVAV | 46 | O95813 | |
| DDVVKIDFEDVIAEP | 61 | Q03135 | |
| SFKVLEARDIQEQPE | 86 | Q6NXP0 | |
| ALDNPNEEVAEVKIS | 66 | Q8IZT6 | |
| VKPSSVEEEDSFFRQ | 676 | Q9UHB7 | |
| QAKDVPVAEEVSALF | 586 | O14617 | |
| SADLEIFPAENFKVT | 956 | Q9UPM8 | |
| FQPAEESVTLEFAKE | 311 | Q5T7V8 | |
| LADKVDSPVIFDLED | 1111 | Q7Z401 | |
| AELSKETNPVVFFDV | 3056 | P49792 | |
| EVFVLPVDVEKENAH | 196 | Q9H714 | |
| QVIALTFEKFDLEPD | 196 | Q15113 | |
| TFVFQEKEDLPVTED | 16 | O95825 | |
| AVVFDVLKVTPEEFA | 41 | Q5JS13 | |
| APSFQEDEVEIKVSE | 131 | Q9Y5H2 | |
| TPEEEQATKQFLEEI | 16 | P43378 | |
| VENQIEKVFDIPSDE | 206 | Q8N442 | |
| VVVLDISDNAPEFEK | 176 | Q96TA0 | |
| RAKFFPEDVSEELIQ | 81 | P35241 | |
| LPEEVEAEVKAAAEI | 226 | Q9Y2X3 | |
| SDIQVKLFVVPADEA | 391 | Q8IV08 | |
| DSLPVVETKEQFQEA | 246 | Q8NFK1 | |
| DVSQAFLEAVAEEKP | 1791 | Q15746 | |
| KSFVESVEEIPFADD | 1511 | Q7RTP6 | |
| PNVKEFTETSAIFED | 301 | P31513 | |
| FTQAKVIINDTEDEP | 2656 | Q86XX4 | |
| VPEELQDKEFAAVLQ | 56 | O75420 | |
| NKEIQDLEESFVPVA | 211 | Q9NPE2 | |
| SHVKFDDLNPEAVEV | 71 | Q9Y6Y0 | |
| SFQLIKVAFDEEVSP | 976 | Q86WG5 | |
| KVAFDEEVSPEVVEI | 981 | Q86WG5 | |
| PEDDVFFIVDVKIED | 656 | Q6UXM1 | |
| DPVVALEAALQFEDT | 1256 | O95714 | |
| PKSISFSVVFQEAED | 1396 | Q9BQS8 | |
| LVQQEDDKPEAVAAR | 156 | P27144 | |
| NKPEVDEAAVDAILS | 1321 | O60333 | |
| PAFAVEDSQLVELTK | 266 | P46020 | |
| EEKDLAVVTQSAEAP | 286 | Q9BX40 | |
| EEVDLVKEADVPSAI | 81 | Q9NYF5 | |
| KVVNSDPVEEAIRFA | 171 | Q08426 | |
| FDDEPKDVASEVNLT | 476 | Q9H501 | |
| SIKDPLQFVFSDEET | 916 | Q9P2D6 | |
| LNVVFEKIPENESAD | 1201 | O60486 | |
| SVPVEEQEEFKQLSD | 171 | Q9BZD4 | |
| LLNFVTIEESKPDDA | 881 | Q9HC56 | |
| LTDVAEKSVQPLADE | 436 | Q01064 | |
| FNSVEEVAKAFPERV | 106 | Q9H706 | |
| LKASDPDTEDDQIIF | 1656 | Q5H8C1 | |
| ANPFKVDLVSEEEVV | 136 | Q8TET4 | |
| PLKEFFVDDSEEIVE | 291 | Q9P265 | |
| EAEFVKLDQAVAAPE | 886 | Q86UK5 | |
| SFVPENLTDVVEKLE | 1096 | Q5S007 | |
| DPNEAVREFAKEIDV | 616 | P54753 | |
| DPLEEVREAAAKTFE | 2016 | Q92616 | |
| KPVIRDELDVSNFAE | 336 | O75582 | |
| KEVADIFNAPSDDEE | 11 | Q96GN5 | |
| EIVSEDIEDFEFTPK | 311 | Q07864 | |
| KVNLFAELTPEEIDE | 431 | Q9NQG6 | |
| TLPVDFVTADKFDEN | 281 | P00558 | |
| DDENLVEVKFARTPV | 226 | A6NEC2 | |
| APSFDDKILEVVAIF | 871 | Q86XP1 | |
| AAESAKELVEIAVPE | 401 | Q9UNW9 | |
| TKEDFLNPDVLDIFI | 306 | Q9Y251 | |
| VAAELVSADKIEDVP | 11 | P49321 | |
| EPSDLEELEQFAKTF | 281 | P14859 | |
| EPVTDNVEKFAIETE | 156 | Q9Y6X9 | |
| TVTVLDVNDEAPVFK | 1711 | Q6V1P9 | |
| AAAKRVTFPSDEDIV | 41 | O75864 | |
| LEDPDSEQTKAFVEA | 31 | P48147 | |
| AIKVLDIDDNSPVFT | 806 | Q96QU1 | |
| PEAEKEKIAEQVADF | 666 | Q9UI47 | |
| AIIKAALEPFQTEED | 86 | P87889 | |
| AIIKAALEPFQTEED | 86 | Q9YNA8 | |
| AIIKAALEPFQTEED | 86 | P62683 | |
| AIIKAALEPFQTEED | 86 | P63145 | |
| AIIKAALEPFQTEED | 86 | Q7LDI9 | |
| AIIKAALEPFQTEED | 86 | P62685 | |
| AIIKAALEPFQTEED | 86 | P63126 | |
| AIIKAALEPFQTEED | 86 | P62684 | |
| DEKPALLSQIDAEFE | 796 | Q14008 | |
| EINEKIAPSFAVESI | 556 | P31327 | |
| IAPSFAVESIEDALK | 561 | P31327 | |
| VENPSEEDAAIVDKI | 681 | Q3L8U1 | |
| AEDFAEQPIKDAVIT | 161 | Q9Y4L1 | |
| ADEVAAAPEQIAADI | 26 | P59665 | |
| AILKENNISEEVEAP | 381 | Q9H4Z3 | |
| TVPAKAEEEAQSLFV | 96 | Q9BZ29 | |
| ADEVAAAPEQIAADI | 26 | P59666 | |
| EVTFESLQEKIPVAD | 591 | Q96JJ3 | |
| EDVDPAKVKEFESLQ | 416 | Q8TD26 | |
| EPESEFIIKIQDIND | 146 | Q9HBT6 | |
| ANVSEEEERKLFSVP | 241 | Q9H6X5 | |
| PDIVTIDLNTFEFAK | 296 | Q8NCL4 | |
| DVPDLVENFDEASKN | 141 | Q96K17 | |
| TFDVDFPKEQLTEEA | 321 | Q9UBS4 | |
| ESIPDTFEDAVNILK | 371 | P23368 | |
| TFAAPSFDDKILEVV | 861 | Q16760 | |
| DLDKVEPAVIEAQNA | 3281 | Q14204 | |
| IKVLDVNDNAPEFAE | 476 | P55285 | |
| EPESEFIIKVQDIND | 141 | P55289 | |
| AVVDAKDAIKENPEF | 76 | Q9NV70 | |
| ELSPETKFIQADVRD | 71 | A6NKP2 | |
| SFLDPEIKAFLEENT | 41 | Q8IXQ9 | |
| SPEDLTVKVQDDFVE | 81 | P02489 | |
| QPAFTIHVDEAEKEA | 96 | P20248 | |
| VFPAEEFEVRVKENS | 1066 | Q9NYQ7 | |
| EQPHAVLFVDEKDVV | 76 | Q9NQC7 | |
| TSEEKDPEEFLNILF | 676 | Q9NQC7 | |
| PIESAEDLAKQTEIA | 646 | P42261 | |
| ALSVADQDKVFDVAP | 416 | Q14147 | |
| AEFVEVEPEAKQEIL | 26 | Q9Y512 | |
| VEAFAKPVPQVDEAE | 186 | Q9NQZ2 | |
| LEKAAEPTLTFEAVD | 631 | O00411 | |
| DLDSPSKEEVFRFVQ | 341 | P36551 | |
| VIDLVFEKAIDEPSF | 791 | O43432 | |
| APALDFTVENVEKAL | 16 | O94829 | |
| VKEENSEEIDFILPF | 536 | O43933 | |
| VQPEAQAKVDVFRED | 6 | Q06323 | |
| DDENLVEVKFARTPV | 226 | P55786 | |
| ATLIPDEVFDAVKSN | 411 | Q9H9A6 | |
| VDKTVLDDPEDAVFV | 231 | A6NJI9 | |
| PAAEVDRLKVTFEDA | 106 | Q86WQ0 | |
| DNHPVFKETEIEVSI | 276 | Q9BZA8 | |
| KAEDIENDAVFPEEQ | 681 | P0DJD0 | |
| KPEFQDLSVEERSFV | 566 | O94955 | |
| VDANEEVEALIVKSP | 291 | P33527 | |
| DKEEIPFVETVSLNE | 221 | Q9NQ35 | |
| SVISQDDFFKPESEI | 31 | Q9NWW6 | |
| KETVFSDDDFNIEPL | 1351 | Q5JY77 | |
| PFVEEVIDNKENSLE | 186 | Q92990 | |
| LAENEDVVVVDKPSS | 226 | Q8IZ73 | |
| PFIFTDVKDAVAEVA | 371 | Q14D33 | |
| VLPEKTDAVNEALES | 1261 | P46939 | |
| PKCVDEVAFQEEVVA | 46 | P35249 | |
| EFIEADAPKEINIDF | 76 | Q2M5E4 | |
| PDTEEALKEFDFLVT | 296 | Q13033 | |
| VKAALADDFDTPRVV | 406 | Q9HA77 | |
| DASQLIFPKEFETAE | 16 | O15514 | |
| AQKDVAFAPEVDREI | 2046 | Q8NF91 | |
| EFVSFSDKPVDQIAV | 2271 | Q8WXH0 | |
| QEAEFERLVAEFPEK | 686 | Q6ZMZ3 | |
| EEETPAVFIRKSFQE | 816 | Q7Z7B0 | |
| EEITPAIVEAFVNDF | 411 | Q6DKJ4 | |
| KTEDSDDIHFEPVVQ | 1021 | P0DJD1 | |
| KVLDVSNSFAVPFDE | 46 | P51665 | |
| NLFPEAKFAVVLEED | 381 | Q8WZA1 | |
| EPDVQKVLDQDTDAI | 366 | Q6ZNJ1 | |
| KANDFEVPERFLEVA | 671 | Q92786 | |
| AVAVDSAPEVAVKED | 51 | O60508 | |
| IFLDDPQAVSDILEK | 221 | Q99460 | |
| ALKRSFEVEEVETPN | 26 | Q9UHD8 | |
| DELDEPIKTVFADVA | 196 | Q86YJ6 | |
| VPVVISKIFEDQAAD | 96 | Q9NY99 | |
| QVVEAEKVVESPDFS | 916 | Q9Y6Y8 | |
| VSVLADEEFLPFKEN | 136 | Q5TEU4 | |
| FEAVVVTNTIPQDEK | 266 | P21108 | |
| VESVDFANAPEESRK | 131 | P29508 | |
| NIEDVAAESPEAIIK | 191 | Q9P2R7 | |
| AIIKAALEPFQTEED | 86 | P63128 | |
| AAAQEAVEEDIPIAK | 111 | P52815 | |
| PDLLIAVKSVAEDFE | 116 | Q6UX72 | |
| KVDEETFVNLPSLVD | 181 | A8MXE2 | |
| RVAPDVDFKAFEEQL | 276 | Q03154 | |
| DEDDFIKAFTDVPSI | 66 | O75122 | |
| VDILFVKDLAFVDPD | 476 | Q9NRU3 | |
| DADVKDDFVQDVPAL | 541 | Q8IWX7 | |
| KAVDIPSFEESNIAV | 846 | Q15468 | |
| DIEEVAASNPELIFK | 176 | Q96I99 | |
| FENVPSLVDEEVKVA | 551 | Q8NHH1 | |
| EDSLTKQPEEVFDVL | 16 | Q13188 | |
| LAPEEDNLSEIFFVK | 1061 | Q86UP3 | |
| AEAFKDVSEPIVFLQ | 236 | O60858 | |
| LQLDSPEDAEFIVAK | 426 | O43242 | |
| PDDVDIVIKLDNTAS | 546 | P51512 | |
| KVFSLEQDPEEAQRV | 916 | Q6ZVD8 | |
| ANKFPDLTVEDLETD | 586 | Q76I76 | |
| ESQKAVVEDEAKAEP | 201 | A8MU46 | |
| EEAEKNAPAIIFIDE | 291 | P55072 | |
| TASVAPKEEVAILDD | 571 | Q92911 | |
| ALDFSPVEETKAEAA | 4581 | Q15413 | |
| IDPVKEEASAATAEF | 91 | P56962 | |
| ADAAFTEVPKDVTVR | 26 | A6NLU5 | |
| FEAVVVTNTIPQEDK | 266 | P11908 | |
| DPEVVFVASLTKADA | 2111 | Q709C8 | |
| AISSEDFDQELVVKP | 446 | O15040 | |
| QIFEEFICSEAPKEV | 116 | O15492 | |
| KSEIFDDQFSVERPD | 76 | A0A1B0GX68 | |
| TEAEKRDPQELVASF | 91 | Q9UHR5 | |
| FEVEEAAEAQAEPKD | 1331 | P11137 | |
| ENQVSVDAFKILEDP | 701 | P07949 | |
| QEPLSFKDVAVVFTE | 31 | Q9UJW7 | |
| EKNFEDSIVPVVLSA | 506 | Q9UJ78 | |
| FEAVVVTNTIPQEDK | 266 | P60891 | |
| EKVQEETTLVDDPFQ | 56 | Q9NZ63 | |
| VIFPAAEDKDQDLIT | 761 | Q00341 | |
| IEFTFDLEKETPDEV | 496 | Q9Y3S1 | |
| SAVLIEDVPFTEKDF | 76 | Q6P5S7 | |
| KNFEVVDLVDVNTPD | 141 | Q9H3M7 | |
| PEENEVTEFFVTLEK | 4341 | Q5T4S7 | |
| VTEFFVTLEKDPQQE | 4346 | Q5T4S7 | |
| IPSERDFFQEVKESE | 76 | O14530 | |
| DFVAAESKEVVPQDG | 1656 | Q69YN4 | |
| DDKVTFEVFVQADAP | 186 | Q93009 | |
| KPIDLTVQVEFAAAE | 186 | Q96EK4 | |
| EALEQKDREDFVPFT | 76 | Q9NZR1 | |
| PKDQDSVAFEDVAVN | 46 | P15621 | |
| EEAIFITLVKENDPE | 986 | Q14966 | |
| FLANAKESPQEEEID | 221 | Q9UJK0 | |
| AQVQEPVTFKDVAVD | 56 | Q8WXB4 | |
| PVTFKDVAVDFTQEE | 61 | Q8WXB4 | |
| ISEDSPVNIDFHVKE | 166 | Q15916 | |
| FATVEVTDKPVDEAL | 41 | Q9NRV9 | |
| DLDKFAAEDIIDPIA | 3411 | O14686 | |
| LAAAAEIDEEPVSKA | 1916 | E9PAV3 | |
| PETFESLVAKLNDAE | 496 | Q9BWU0 | |
| EDVASIFLQVVDVPD | 626 | Q14324 |